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ABSTRACT 
Skeletal muscle injury may occur from repetitive short bursts of biomechanical strain that 
impair muscle function. Alternatively, variations of biomechanical strain such as those held for 
long-duration are used by clinicians to repair muscle and restore its function. Fibroblasts 
embedded within the unifying connective tissue of skeletal muscle experience these multiple and 
diverse mechanical stimuli and respond by secreting cytokines. Cytokines direct all stages of 
muscle regeneration including myoblasts differentiation, fusion to form myotubes, and myotube 
functionality. To examine how fibroblasts respond to variations in mechanical strain that may 
affect juxtapose muscle, a myofascial junction was bioengineered that examined the interaction 
between the two cell types. Fibroblasts were experimentally shown to increase myoblast 
differentiation, and fibroblast biomechanical strain mediated the extent to which differentiation 
occurred. Intereleukin-6 is a strain-regulated cytokine secreted by fibroblasts was determined to 
be necessary for fibroblast-mediated myoblast differentiation. Myotubes differentiated in the 
presence of strained fibroblasts express greater number of acetylcholine receptors, greater 
acetylcholine receptor sizes, and modified to be more or less sensitive to acetylcholine-induced 
contraction. This study provides direct evidence that strained and non-strained fibroblasts can 
serve as a vehicle to modify myoblast differentiation and myotube functionality. Further 
understanding the mechanisms regulating these processes may lead to clinical interventions that 
include strain-activated cellular therapies and bioengineered cell engraftment for mediating the 
regeneration and function of muscle in vivo. 
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CHAPTER 1. STRATEGIC REGULATION OF SKELETAL MUSCLE REPAIR AND FUNCTION 
BY FIBROBLASTS 
Introduction 
Be it from impact trauma or degenerative disease, over 6 million musculoskeletal injuries 
are diagnosed annually in the United States (Woolf, Erwin et al. 2012).  Therefore, implementing 
strategies to repair skeletal muscle and drive the repair process to completion is significant.  One 
particular strategy invokes the use of endogenous cells within the body to secrete mediators into 
the extracellular milieu that activate the skeletal muscle repair process. Muscle repair centers on 
the differentiation and fusion of myoblasts to form myotubes, the smallest functional unit of the 
muscle (Collins, Olsen et al. 2005). Therefore, facilitating myoblast differentiation through 
endogenous means is deserving of examination in great detail. Local fibroblasts interact with 
skeletal muscle through paracrine mechanisms to coordinate myoblast differentiation (Murphy, 
Lawson et al. 2011). Fibroblasts are highly interactive and responsive to environmental cues, thus 
targeting fibroblasts to behave in manners that create favorable conditions for driving muscle 
repair to completion would be of interest. One promising method is to manipulate the response of 
fibroblasts through biomechanical strain. Biomechanical strain induces fibroblasts to synthesize 
and secrete unique cytokine profiles (Meltzer and Standley 2007) that, in turn, may differentially 
affect the underlying muscle. Importantly, it is known that high-impact and repetitive strain 
regimens can induce muscle injury, and long-duration sustained strain regimens are clinically 
practiced to repair injury. Fibroblasts embedded within muscle fascia are exposed to these 
variations in mechanical strain and may respond by secreting cytokines that promote or prohibit 
muscle repair.  
As myotubes mature they express and cluster nicotinic acetylcholine receptors (nAChRs) 
that receive stimulatory input required for contraction. NAChR expression and clustering on the 
sarcolemma exhibits high plasticity in response to the functional demands and physiological state 
of the muscle. Fibroblasts may serve as one cell type of particular importance in regulating 
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nAChR plasticity as they are abundant and juxtaposed to sarcolemmal nAChRs. Cytokines 
regulate the functional phenotype of the skeletal muscle (Borselli, Storrie et al. 2010), and 
therefore strained and non-strained fibroblasts which also produce cytokines may serve as an 
endogenous cell type within the body regulating muscle function through the expression and 
clustering of nAChRs. 
Expanding our knowledge on how fibroblasts and mechanical strain regulate myoblast-to-
myotube differentiation, and direct phenotypic changes of functional myotubes will not only 
improve our understanding of the muscle repair process, but may also provide evidence leading 
to novel and innovative clinical procedures that further promote muscle repair. Be it through 
guided osteopathic manipulative techniques, surgical engraftment of muscle flaps embedded with 
strain-activated fibroblasts, or synthesizing compounds that replace fibroblast-derived cytokines 
in the extracellular milieu with pharmaceutical mimics, studying the strain-activation of fibroblasts 
and subsequent effects on muscle may establish important proof-of-concepts that lead to future 
therapies. My work uses a novel in vitro coculture model to investigate fibroblast regulation of 
skeletal myoblast differentiation- the essential step of muscle repair- and investigate the 
functional influences of fibroblasts on myotubes, differentiated in their presence, in the context of 
expression and clustering of acetylcholine receptors that may ultimately modulate muscle 
contraction.   
Fibroblasts Embedded within Muscle Fascia Juxtapose Skeletal Muscle  
Fascia is the soft-tissue component of the connective tissue system permeating 
throughout the human body. It forms a unifying, three-dimensional web-like structure that extends 
to ligaments, tendons, and intramuscular connective tissue resulting in a mechanically 
interconnected environment. Highlighting this interconnected system in skeletal muscle, the 
epimysial layers that ensheathe muscle bundles are continuous with tendons, and the perimysial 
and endomysial layers that ensheathe muscle fascicles and individual myofibers, respectively, 
are continuous with the epimysium at the surface of the muscle (Findley 2009). Thus mechanical 
strain applied to muscle fascia at one anatomical location will result in mechanical stain at distant 
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anatomical locations and designates the muscle fascia as an important load bearing structure. 
Although general names for connective tissues associated with skeletal muscle are 
interchangeably referred to as stroma, interstitium, or intramuscular connective tissue, the term 
muscle fascia will be used here. Additionally, the myofascial junction will be defined as all 
anatomical locations where muscle fascia borders the skeletal muscle such as at the basal 
lamina (Figure 1).  In this study we bioengineered a simple myofascial junction to investigate the 
interaction between skeletal muscle and fibroblasts, the main cell type of muscle fascia (Figure 
4).  
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Figure 1. Meet the Neighbors: Muscle Fascia and Skeletal Muscle. Muscle fascia interpolates 
through skeletal muscle with dense regular connective tissues, containing closely packed bundles 
of collagen fibers oriented in a wavy pattern parallel to the direction of pull.  The fibrous tissue 
sheaths of epimysium delineate the surface of the muscle, the perimysium separates muscle 
fascicles, and the endomysium borders individual myofibers. Not depicted, penetrating through 
muscle fascia are blood vessels which supply nutrients and neurons which stimulate contraction. 
The primary cell type of the fascia is the fibroblast which interacts with the underlying skeletal 
muscle through paracrine mechanisms.   
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Fascia fibroblasts are abundant comprising up to 50% of the skeletal muscle cell 
population depending on age and health of the individual. Fibroblasts originate from the lateral 
plane of the mesoderm and are a separate lineage from their neighboring somatically-derived 
myogenic cells (Kardon, Harfe et al. 2003). Thus they do not naturally provide nuclei for the 
regenerating muscle as other stromal cells do (Dellavalle, Maroli et al. 2011). Fascia fibroblasts’ 
primary role is to synthesize and maintain collagen fibers needed to structurally support the 
muscle and an amorphous matrix of proteoglycans, such as hyaluronic acid, that serve as a 
viscoelastic shock absorber and lubricant during muscle contraction (Stecco, Stern et al. 2011). 
The amounts and composition of fascia structures vary based on anatomical location, and are 
dependent upon a dynamic balance of growth, remodeling, and degradation by the fibroblasts. 
Fibroblasts have evolved to meet the functional demands of the skeletal muscle and surrounding 
biophysical environment by synthesizing and secreting a repertoire of cytokines that help 
modulate the extracellular matrix and nearby cellular behavior (Purslow 2010). For example, 
fibroblasts secrete proteases and protease inhibitors, such as matrix metalloproteinases (MMPs) 
and tissue inhibitors of matrix metalloproteinases (TIMPs) that remodel the extracellular matrix, 
and dually serves as a molecular scaffold for cellular remodeling during wound healing. Fibroblast 
also secrete chemokines that attract infiltrating leukocytes during muscle injury (Buckley, Pilling et 
al. 2001) and induce cellular migration of muscle satellite cells to the site of damaged myofibers 
(Ratajczak, Majka et al. 2003).   
Fibroblast cytokines and growth factors are also directly important for wound healing and 
regeneration. I previously collaborated on a study evaluating a three-dimensional fibroblast 
construct (3DFC) that promoted angiogenesis and left ventricular function after myocardial infarct. 
The 3DFC secreted growth factors including hepatocyte growth factor (HGF), vascular endothelial 
growth factor (VEGF), basic fibroblast growth factor (bFGF), and others (Michael Hicks, Kate 
Meltzer et al. 2008).  We applied biomechanical strain modeling a heartbeat to the 3DFC, and 
determined that many of these cytokines and growth factors are strain-regulated. The 3DFC is 
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currently in a Phase IIb Clinical Trial for patients with end stage heart failure and patients 
undergoing elective coronary artery bypass grafting (Lancaster, Juneman et al. 2010). 
Fascia Fibroblasts Sense and Respond to Biomechanical Strain by Secreting Cytokines Involved 
with Muscle Repair 
 
Mechanical loading and deformation play important roles in the development and 
physiology of a variety of tissues. From large mechanical forces applied to chondrocytes in 
cartilage matrices to the relatively weak mechanical forces applied to kidney microtubules, cells 
sense physical aspects of their environment and respond appropriately to ensure proper cell 
function (Chiquet, Renedo et al. 2003).  
The transduction of mechanical signals to biochemical signals occurs through several 
signaling pathways reviewed by Katsumi and colleagues (Katsumi, Naoe et al. 2005). 
Collectively, mechanosensors work through three basic mechanisms: by partial protein unfolding 
which regulates protein tertiary structure and modifies gain or loss of function of enzymatic 
activity; by opening mechanosensitive ion channels through membrane tension; and by stabilizing 
receptor-ligand bonds that counteract force-induced breakage (Vogel and Sheetz 2006). Through 
these mechanisms force-induced perturbations varying in direction, duration, magnitude, and 
frequency elicit a number of unique downstream responses. Thus biomechanical strain variation 
has important roles in regulating cellular function. 
Muscle fascia fibroblasts are important mechanosensors of the extracelluar environment 
as their structural support and unification role in skeletal muscle places them under continual 
strain loads. As fibroblasts are pulled by their environment, cellular forces and cellular-generated 
matrices create new signals, such as those originating from fibronectin unfolding. Signals are 
transmitted through mechanoreceptors to the cytoskeleton to activate signaling cascades, such 
as phosphorylation of MAPK (Danciu, Gagari et al. 2004). The activation and translocation of 
these intracellular signaling pathways to the nucleus results in changes to gene transcription 
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which regulate fibroblast proliferation, apoptosis, differentiation, and hypertrophy (Vogel and 
Sheetz 2006).  
Mechanotransduction also affects the secretion of fibroblast-derived cytokines. One 
example is through the phosphorylation of the JNK/AP-1 (activator protein-1) pathway which 
initiates Interleukin-6 transcription (Whitham, Chan et al. 2012). Interleukin-6 (IL-6) is a pleotropic 
cytokine known to be highly involved in skeletal muscle regeneration. We believe IL-6 is an 
important strain-regulated cytokine and its mechanism of action in skeletal muscle differentiation 
processes will be introduced in the context of muscle regeneration shortly. Importantly, our 
laboratory has previously shown that strain variations in magnitude and duration up-regulate 
fibroblast IL-6 secretion suggesting that strain variations placed on fibroblasts, in turn, affect 
muscle repair (Dodd, Good et al. 2006). In addition to IL-6 we have shown that mechanical strain 
elicits the unique secretion of other cytokines (Figure 2) that also may influence the degeneration 
or repair of skeletal muscle. Studying the mechanical induction of cytokines that modify cellular 
processes could lead to clinical interventions that may halt the progression of chronic 
musculoskeletal disorders and disability (Barr and Barbe 2002).   
Clinical Evidence Suggests Fibroblasts are Important Regulators of Muscle Injury and Repair 
during Repetitive Strain and Manipulative Therapy 
Cyclic short-duration strains (CSDS) such as those experienced during lifting, running, 
hammering, and keyboarding result in numerous musculoskeletal injuries that include muscle 
strains and sprains, tendonitis, bursitis, and fasciitis. These injuries result in debilitating quality of 
life, and will likely be experienced by every individual in their lifetime. For example, for every 1000 
hours of running between 7 and 59 CSDS injuries occur per person (Lopes, Hespanhol et al. 
2012). While athletes are at high risk for CSDS injuries, those with preexisting injuries, chronic 
illnesses such as cancer and HIV-induced cachexia, genetic disorders such as muscular 
dystrophy and ALS, and the elderly are especially sensitive to CSDS-related disorders. CSDS is 
agonistic of other injuries such as lower back pain and neck pain that are estimated to affect 40.5 
and 16.4 million adults, respectively; and are estimated to cost $193.4 billion in annual medical 
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expenses in the United States (Tak and Calvert 2011). Thus methods aimed to prevent, 
attenuate, and treat CSDS injuries are important for individuals from all demographics, and 
understanding the underlying mechanisms which cause CSDS injuries is crucial to their 
development.  
CSDS-models such as the one used by Carpenter et al. subjected mice to 7500 forelimb 
strides, as would be experienced by the rotator cuff during an elite swimming event, resulting in 
the expansion of extracellular matrix deposition (i.e. fibrosis) around skeletal muscle causing fiber 
necrosis and muscle wasting (Carpenter, Flanagan et al. 1998). Other models used by Kietrys 
and colleagues show a dose-dependent increase in muscle inflammation (Kietrys, Barr et al. 
2011),  and pain (Howatson and Van Someren 2008).  CSDS may also cause ischemia and 
neurological dysfunction shown to reduce fine motor control and muscle dysfunction, conceivably 
by affecting neuromuscular communication (Barr and Barbe 2002). While fibroblasts are 
important to wound healing and regeneration, during persistent and chronic injuries fibroblasts 
phenotypically switch to become the key producers of fibrosis, the hallmark of CSDS pathology 
(Serrano and Munoz-Canoves 2010), and inflammatory cytokines which cause further muscle 
damage  (Flavell, Hou et al. 2008). To investigate the phenotypic switch of fibroblasts during 
CSDS, we previously developed an in vitro system to strain fibroblasts in manners modeling 
CSDS. We have shown alterations to fibroblast morphology resembling in vivo injury and 
upregulated proinflammatory cytokines as described clinically (Meltzer, Cao et al. 2010). Of the 
60 cytokines measured, 35 cytokines (58%) were increased by ≥1.5-fold 24 hours after CSDS 
(Figure 2). Many of these CSDS-derived cytokines have documented catabolic effects on skeletal 
muscle fibers (Cannon and St Pierre 1998). CSDS-fibroblasts secreted cytokines in a delayed 
manner supporting the idea that the in vitro CSDS is interpreted by the fibroblasts as an injury. 
Delays in hours to days in cytokine induction, inflammation, and pain after a CSDS-injury have 
previously been reported. For example, delayed-onset muscle soreness is typically manifested 3 
days after injury, and is associated with inflammation and cytokine induction. Therefore targeting 
fibroblasts and fibroblast-rich tissues, which have been subjected to CSDS, with intervening 
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therapies prior to the delayed secretion of muscle-specific catabolic cytokines may serve as a 
strategy to reduce CSDS-induced muscle injury.    
Patients seeking therapy from CSDS-injuries are often prescribed corticosteroids, 
lidocaine, or other substances such as non-steroidal anti-inflammatory drugs for pain relief and 
inflammatory reduction. However, CSDS-induced cytokines enhance hyper-fibrosis that is 
followed by irreversible restrictions that can span weeks, months, or even years (Hinz, Phan et al. 
2012), and leads to permanent dysfunction, altered mechanotransduction, and injury recurrence. 
While medications may temporarily alleviate symptoms and reduce inflammation, the underlying 
structural disorganization may still cause devastating effects to muscle function, and impede the 
regeneration process by inhibiting satellite cell migration and paracrine signaling between cell 
types (Serrano and Munoz-Canoves 2010). Patients may elect to undergo surgical intervention to 
restore structural architecture of the extracellular tissue. However, procedures are expensive, 
invasive, require long recovery time, and result in worsened post-operative pain in 10% of 
individuals (Bland 2007). For these reasons it is estimated that only 3% of the population seek 
surgical treatment for CSDS injuries. 
Osteopathic manipulative treatment, physical therapy regimens, stretch exercises, and 
acupuncture are examples of complementary and alternative treatments that offer a less 
expensive and non-invasive treatment for CSDS injury. These treatments typically apply guided 
acyclic long-duration strain (ALDS) to correct fibroblast morphology, ECM and muscle positioning 
that restore mobility. In turn, these therapies decrease inflammation, facilitate neuromuscular 
reflexes, and improve physical performance deficits caused by CSDS (Sucher, Hinrichs et al. 
2005; Zainuddin, Newton et al. 2005; Corrie A. Mancinelli and Foutty 2006; Bertolucci 2010). 
Osteopathic manipulative treatments are also applied to areas anatomically distant to an injury, 
suggestive of a potential role for systemic mediators (Nicholas and Oleski 2002).   
Fibroblasts respond to mechanical stimuli within seconds, thus the minutes of sustained 
ALDS typically applied during treatment should be sufficient time to stimulate a fibroblast 
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response. These early responses may involve cytoskeletal redistribution, changes in cell 
migration, and secretion of cytokines (Vogel and Sheetz 2006). Of the 60 cytokines tested in a 
previously study by our laboratory, an ALDS applied three hours post CSDS strain attenuated 33 
of the 37 CSDS-upregulated cytokines (Figure 2, (Meltzer, Cao et al. 2010)). 
Despite clinical studies showing functional improvements and in vitro studies showing 
alterations in fibroblast-derived cytokines, there is no study to our knowledge that has 
investigated the direct effects of fibroblasts and strain on muscle repair processes.  A better 
understanding of the muscle repair process as mediated by fibroblasts and strain may provide 
further insight into the mechanisms of muscle injury and serve as a possible guide for effective 
and efficient treatment modalities.  
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Figure 2. Cytokines Secreted by Fibroblasts in Response to Strain Paradigms. Sixty 
identified cytokines secreted by fibroblasts measured immediately after CSDS (A) and 24 hours 
post-CSDS (B). The indirect osteopathic manipulative treatment (IOMT) was measured at 24 
hours post-strain either alone (C) or following CSDS (D).  Grey bars represent cytokines ≥1.5-fold 
vs. non-strain fibroblasts.  
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Muscle Regeneration from Myoblast Differentiation to Functional Myotube 
Muscle regeneration is a well-orchestrated event involving multiple cell types that include 
satellite cells, myofibers, immune cells, neurons, fibroblasts and other stromal cells. A recent 
review of the dynamic coordination among these cells to bring about muscle regeneration can be 
found by Dr. Michael Rudnicki and colleagues (Bentzinger, Wang et al. 2013). Here, the main 
process by which satellite cells regenerate skeletal muscle and the potential involvement of 
fibroblasts and strain will be introduced. Throughout Chapter 4, possibilities by which fibroblasts 
and strain integrate with multiple cell types to regulate muscle regeneration will be addressed, 
and speculations to how fibroblasts and strain might serve in a broad range of clinical applications 
will be considered. 
After muscle injury, a biphasic response characterized by an inflammatory phase and a 
regenerative phase serve to repair the damaged site. The inflammatory phase is characterized by 
the recruitment of neutrophils and tissue macrophages that remove necrosed tissue. During this 
phase, quiescent satellite cells (SCs) that rest at the periphery of mature myofibers and beneath 
its basal lamina, are activated through molecular signals to express myogenic markers of 
myoblasts, such as MyoD (Charge and Rudnicki 2004). During the regenerative phase, 
myoblasts proliferate extensively in order to efficiently repair an appropriately sized muscle. 
Myoblasts either self-renew the satellite cell population and return to a state of quiescence, or 
migrate to the damaged zone and differentiate into post-mitotic myotubes. Myoblast differentiation 
is accomplished through the expression of several de novo transcription factors, such as 
myogenin and MRF4 which regulate the transcription of  greater than 1,500 myotube-specific 
genes including those involved with exiting the cell cycle, building sarcomeres, and embedding de 
novo receptors into the nucleus and plasma membrane to communicate with neighboring cells 
(Tannu, Rao et al. 2004). As differentiation proceeds myoblasts fuse with other myoblasts, or with 
preexisting myofibers, to replace or repair functional muscle (Figure 3). Myoblasts’ ability to 
optimally fuse and add nuclei to myotubes is crucial to restoring muscle architecture and will 
ultimately dictate myotube size and strength (Petrella, Kim et al. 2008; Van Wessel, De Haan et 
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al. 2010).  We explore this differentiation process in Chapter 2 and the integrated effects of 
fibroblasts, strain, and IL-6 on this process. 
Once functionally mature, myotubes express nicotinic acetylcholine receptors (nAChRs) 
that receive stimulatory input to contract. Acetylcholine (ACh) released by an innervating α-
motoneuron binds to nAChRs embedded in the muscle post-synaptic endplate to open 
transmembrane channels that cause an influx of Na+ into the myotube, eventually resulting in 
action potentials. Thus expression and clustering of nAChRs regulate muscle function through 
binding ACh that subsequently depolarizes the sarcolemma.  Nicotinic receptors are an important 
therapeutic target for chronic diseases such as amyotrophic lateral sclerosis in which 
neuromuscular denervation is followed by degeneration of α-motoneurons and muscle atrophy; 
and studying nicotinic receptors has led to a broad range of clinical treatments from glaucoma to 
neurotoxins. Thus strategies that promote neuromuscular communication through regulation of 
nAChRs warrant further investigation (Gifondorwa, Jimenz-Moreno et al. 2012). In chapter 3, I 
introduce the concept of fibroblast-regulated neuromuscular plasticity, the process by which of 
neuromuscular junctions remodel, in the context of nAChRs. 
Fibroblasts represent a likely source of the molecular signaling that directs each stage of 
muscle regeneration through to functional completion (Gopinath and Rando 2008). The idea that 
the fibroblasts are important regulators of muscle regeneration process has recently been 
explored by Kardon and colleagues through the creation of Tcf4CreERT2 mice. Genetic ablation of 
Tcf4+ fibroblasts reduced Pax7+ satellite cells by 51%, establishing evidence that muscle fascia 
fibroblasts are a vital component regulating satellite cell expansion during muscle regeneration  
(Murphy, Lawson et al. 2011).  While that study did not identify which molecular signals 
fibroblasts use to regulate regeneration, it seems likely that fibroblast-derived IL-6 would be 
involved. IL-6 activates the JAK/STAT-3 pathway to increase myoblast proliferation (Serrano, 
Baeza-Raja et al. 2008), IL-6 deficient mice decrease myoblast fusion efficiency by 40% 
compared to wild type during mechanical overload-induced muscle hypertrophy. The fusion 
efficiency of myoblasts is an integral part of the differentiation process as myonuclear accretion 
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allows for increased translation of muscle-specific proteins; although the extent to which myotube 
hypertrophy occurs independently of myoblast fusion remains to be established (Jackson, Mula et 
al. 2012). Fibroblast IL-6 regulation via biomechanical strain activation of mechanoreceptors 
(Stockbridge and French 1988) may imply that fibroblasts regulate myoblast differentiation and 
myotube hypertrophy though biomechanical strain. Therefore in this study, we decided to include 
myonuclear accretion, fusion efficiency, and IL-6 secretion measurements in our investigation of 
fibroblasts and strain regulation of myoblast differentiation.  In addition, we were specifically 
interested in fibroblast effects on the functionality of resultant myotubes. It has been shown that 
mediators, such as TNFα and IFNλ which are secreted by fibroblasts in different biomechanical 
contexts, regulate myotube nAChR expression and thereby may affect the functional phenotype 
of the myotube (Poea-Guyon, Christadoss et al. 2005). Wnt signaling also alter the effects agrin-
induced nAChR clustering (Henriquez, Webb et al. 2008) and therefore paracrine mediators 
secreted by fibroblasts in the context of clustering were also explored. 
While the activation of satellite cells and the preservation of a quiescent state has 
recently been explored (Gilbert and Blau 2011; George, Biressi et al. 2013) and has important 
clinical implications for donor satellite cell muscle engraftment (Boldrin, Neal et al. 2012), this 
work investigates the novel and downstream effects of mechanical strain on fibroblast-mediated 
myoblast differentiation and fusion carried through to myotube functionality.  
We hypothesize fibroblasts would enhance parameters of myoblast differentiation and 
increase the contractile sensitivity of myotubes differentiated in their presence. Contractile 
sensitivity should correlate with increased expression and clustering of nAChRs. Fibroblasts 
secrete IL-6 in a strain-dependent manner, and we hypothesize strain-activated fibroblasts, which 
secreted the greatest amount of IL-6, would proportionally increase myoblast differentiation. 
Biomechanical strain applied to fibroblasts should also influence the ability of myoblast to 
differentiate and myotubes to function. CSDS induces the secretion of several proinflammatory 
and catabolic cytokines known to inhibit myoblast differentiation, thus CSDS should attenuate 
fibroblast-mediated myoblast differentiation. However, Guyon et al. showed TNFα and IFNλ, 
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which we previously identified to be secreted by CSDS-fibroblasts, increase the expression of 
nAChR through a compensatory mechanism (Guyon, Wakkach et al. 1998), thus we 
hypothesized myotubes differentiated by CSDS-fibroblasts would express greater amounts of 
nAChRs, which would likely enhance myotube contractile sensitivity.   
Through experimentation we provide evidence supporting fibroblast-mediated myoblast 
differentiation and alternations in myotube contractile sensitivity. While we found IL-6 is 
necessary for fibroblast-mediated myoblast differentiation and fusion to myotubes, we were 
surprised to find that IL-6 secretion did not correlate with myoblast differentiation at the time of 
analysis. The application of CSDS+ALDS followed a similar trend to CSDS in most cases, 
although myoblast differentiation numbers were restored to non-strain levels. While CSDS-
fibroblasts attenuated myoblast differentiation, those myotubes which differentiated produced the 
greatest nAChRs and were most sensitive to ACh-induced contraction. We discovered ALDS-
fibroblasts maintain nAChRs in macroclusters and preserved IL-6 in the media, while CSDS-
fibroblasts disrupted nAChR macroclusters and reduced IL-6 in the media at the time of myotube 
analysis. These results suggest that fibroblasts regulate several outcomes of myoblasts 
differentiation and myotube function, and biomechanical strain has profoundly different effects on 
these processes. The implications of these data will be discussed throughout the body of this 
work and clinical significance addressed in the concluding chapter. 
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Figure 3. Satellite Cells Respond to Injury and Potential Roles for Fibroblasts. In response 
to muscle injury, satellite cells are activated and proliferate. Some satellite cells will reestablish a 
quiescent satellite cell pool through a process of self-renewal, while others cells will migrate to the 
damaged region and fuse with existing myofibers or align and fuse to produce new myofibers. In 
the regenerated myofiber, the newly fused satellite cell nuclei will initially be centralized but will 
later migrate to assume a more peripheral location characteristic of a mature myofiber. We were 
interested in the effects of strain and fibroblasts on mediating myoblast differentiation and 
myotube functional maturity as denoted by green arrows (Hawke and Garry 2001). 
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CHAPTER 2. MECHANICAL STRAIN APPLIED TO HUMAN FIBROBLASTS DIFFERENTIALLY 
REGULATES MYOBLAST DIFFERENTIATION 
 
Abstract 
 
Cyclic short-duration stretches (CSDS) such as those resulting from repetitive motion 
strain increase the risk of musculoskeletal injury. Myofascial release is a common technique used 
by clinicians that applies an acyclic long-duration stretch (ALDS) to muscle fascia to repair injury. 
When subjected to mechanical strain, fibroblasts within muscle fascia secrete IL-6, which has 
been shown to induce myoblast differentiation, essential for muscle repair. We hypothesize that 
fibroblasts subjected to ALDS following CSDS induce myoblast differentiation through IL-6.  
Fibroblast conditioned media and fibroblast-myoblast co-cultures were used to test fibroblasts’ 
ability to induce myoblast differentiation. The co-culture system applies strain to fibroblasts only, 
but still allows for diffusion of potential differentiation mediators to unstrained myoblasts on 
coverslips. To determine the role of IL-6, we utilized myoblast unicultures±IL-6 (0-100ng/ml) and 
co-cultures±α-IL-6 (0-200µg/ml). Untreated uniculture myoblasts served as a negative control. 
After 96hrs, coverslips (N=6-21) were microscopically analyzed and quantified by blinded 
observer for differentiation endpoints: myotubes/mm2 (>3 nuclei/cell), nuclei/myotube, and fusion 
efficiency (% nuclei within myotubes). The presence of fibroblasts and fibroblast conditioned 
media significantly enhanced myotube number, p<0.05. However, in co-culture, CSDS applied to 
fibroblasts did not reproduce this effect.  ALDS following CSDS increased myotube number by 
78% and fusion efficiency by 96% vs. CSDS alone, p<0.05.  Fibroblasts in co-culture increase IL-
6 secretion; however, IL-6 secretion did not correlate with enhanced differentiation among strain 
groups. Exogenous IL-6 in myoblast uniculture failed to induce differentiation. However, α-IL-6 
attenuated differentiation in all co-culture groups, p<0.05.  Fibroblasts secrete soluble mediators 
that have profound effects on several measures of myoblast differentiation. Specific biophysical 
strain patterns modify these outcomes, and suggest that myofascial release after repetitive strain 
increases myoblast differentiation, and thus may improve muscle repair in vivo. Neutralization of 
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IL-6 in co-culture significantly reduced differentiation suggesting fibroblast-IL-6 is necessary but 
not sufficient in this process.  
Introduction 
 
Repetitive motion strain (RMS) in combination with forceful movements increases risk of 
muscle tears, ligament sprains,  joint inflammation, and fascia disruption  (Barr and Barbe 2002). 
In 2010 the U.S. Bureau of Labor Statistics reported 35,920 work-related RMS injuries, requiring 
a median of 24 missed work days per incident. RMS injuries expand extracellular matrix 
deposition (i.e. fibrosis) around skeletal muscle causing fiber necrosis, muscle wasting, and pain 
(Howatson and Van Someren 2008). Patients seeking therapy from RMS injury often undergo 
surgery, even though procedures are invasive, require long recovery time, and result in worsened 
post-operative pain in 10% of individuals (Bland 2007). From a biophysical perspective RMS 
induces cyclic short-duration stretches (CSDS).  Manual manipulation offers a less expensive and 
non-invasive treatment for RMS injury. Manual manipulation applies extracorporeal forces to an 
affected tissue to restore mobility, decrease inflammation, and improve physical performance 
(Sucher, Hinrichs et al. 2005; Zainuddin, Newton et al. 2005; Corrie A. Mancinelli and Foutty 
2006). The most widespread manual manipulation modality directed at alleviating muscle fascia 
restrictions is myofascial release. This technique stretches the long and transverse axes of an 
affected area for typically ≥60 seconds for immediate as well as long-term pain relief (Andersson, 
Lucente et al. 1999; Hou, Tsai et al. 2002).  Myofascial release may also be applied to areas 
anatomically distant to an injury, suggestive of a potential role for systemic mediators (Nicholas 
and Oleski 2002).  Importantly, and in context to RMS, myofascial release induces an acyclic 
long-duration stretch (ALDS). 
Mechanical forces act upon fascia-embedded fibroblasts to affect cytokine release that in 
turn mediate inflammation, cell migration, proliferation, and differentiation. Studying the 
mechanical induction of these cytokines in response to strain variations that modify these cellular 
processes could lead to clinical interventions that may halt the progression of chronic 
musculoskeletal disorders and disability (Barr and Barbe 2002).  We have previously developed 
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in vitro models of CSDS, ALDS, and a combined cyclic short-duration stretch with an acyclic 
longer-duration stretch (CSDS+ALDS) paradigm using fibroblasts seeded on flexible membranes. 
In a manner similar to that observed with muscle injury (Nakama, King et al. 2007), we have 
shown that CSDS dramatically impacts fibroblast actin morphology and cellular condensation 
(Meltzer, Cao et al. 2010), and ALDS applied three hours post-CSDS reverses this effect 
(Meltzer, Cao et al. 2010). We’ve also shown that our strain paradigms modify fibroblast cytokine 
output (Dodd, Good et al. 2006; Meltzer and Standley 2007). Fibroblasts secrete insulin-like 
growth factors (IGFs), fibroblast growth factors (FGFs), hepatocyte growth factor (HGF), 
interleukins (ILs), and nitric oxide (NO) involved in skeletal muscle regeneration (Cannon and St 
Pierre 1998; Badylak 2002; Tettamanti, Grimaldi et al. 2004). Of interest, we’ve shown 
Interleukin-6 (IL-6) is mechanically up-regulated 24 hours after CSDS. IL-6 acts on the AMP-
kinase pathway in skeletal muscle to activate glucose uptake and fatty-acid oxidation needed for 
growth and repair (Al-Khalili, Bouzakri et al. 2006; Pedersen and Febbraio 2008), and has been 
shown to stimulate skeletal muscle hypertrophy in vivo (Serrano, Baeza-Raja et al. 2008) and 
myoblast proliferation and differentiation in vitro (Baeza-Raja and Munoz-Canoves 2004). 
Muscle fascia is anatomically juxtaposed to underlying skeletal muscle functioning in 
locomotion and as a molecular scaffold for cellular remodeling (Purslow 2010). Muscle fascia 
fibroblasts may also influence muscle hyperplasia and repair through paracrine cytokine activity 
(Quinn, Ong et al. 1990; Cooper, Maxwell et al. 2004).  The process begins when quiescent 
satellite cells, which reside at the periphery of myotubes, are activated through molecular signals 
to express myogenic markers of myoblasts (Hawke and Garry 2001). Myoblasts then proliferate 
extensively to self-renew the satellite cell population, or form terminally differentiated myotubes. 
Myoblasts that undergo differentiation exit the cell cycle and fuse with other myoblasts to form 
multinucleated myotubes that repopulate the injured site with functional muscle (Charge and 
Rudnicki 2004). Myoblasts’ ability to optimally fuse and add nuclei to myotubes is crucial to 
restoring muscle architecture, and will ultimately dictate myotube size and strength (Petrella, Kim 
et al. 2008; Van Wessel, De Haan et al. 2010). Signaling molecules direct each stage of muscle 
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repair (Gopinath and Rando 2008), and fibroblasts, via biomechanical strain induced activation of 
mechanoreceptors (Stockbridge and French 1988), represent a likely source of these signals.  
In this study, we investigated the mechanism by which fibroblast manipulation could be 
responsible for accelerated recovery from muscle injury. We additionally sought to determine 
whether ALDS without injury could influence muscle repair. C2C12 skeletal muscle myoblast 
differentiation was measured in response to fibroblasts strained with CSDS, ALDS, or a combined 
CSDS+ALDS, in vitro. We used fibroblast conditioned media and constructed a novel myoblast-
fibroblast co-culture (Figure 1C) that allowed us to directly measure paracrine effects of 
fibroblasts on myoblast growth and differentiation.  We hypothesized that fibroblasts exposed to 
CSDS inhibit myoblast differentiation, and treatment with ALDS reverses CSDS-inhibited 
differentiation. We also hypothesized that ALDS alone increases differentiation vs. non-strained 
through the release of IL-6. We sought to identify a role for IL-6 in mediating these effects and its 
incorporation into a potential molecular and cellular-based mechanism supporting the clinical 
efficacy of myofascial release.  
Materials and Methods 
Cell cultures 
All studies were carried out using human dermal fibroblasts (NHDF) from Cambrex 
Laboratories (East Rutherford, NJ) and C2C12 skeletal muscle myoblasts from American Tissue 
Culture Collections (Manassas, VA).  Cells were maintained at 37°C, 5% carbon dioxide, and 
100% humidity in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 2% or 10% 
fetal bovine serum (FBS) depending upon the experimental conditions (see below). Differentiation 
media (2% horse serum, American Tissue Culture Collections) was used a positive control for all 
experiments, and to verify that our cells were capable of differentiating into myotubes (McFarland 
1987). Cell cultures were fed every day with fresh media and passaged when confluent. All 
experiments used passage numbers between 3 and 8. 
Strain Apparatus and Strain Paradigms 
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The Flexercell FX-4000 Tension Plus System (Flexcell International Corp, Hillsborough, 
NC) is a computer-controlled device designed to deliver vacuum assisted stretch regimens to 
Bioflex® culture plates. Bioflex plates have an elastomeric surface that allows the fibroblasts that 
are adherent to its surface to deform under vacuum. Strain paradigms are created by 
programming the strain magnitude, duration, and frequency of the negative pressure to create the 
desired regimen (Vande Geest, Di Martino et al. 2004). We have used this apparatus to 
effectively model aortic pressure waveforms (Standley, Stanley et al. 2001), repetitive motion 
strain (Meltzer and Standley 2007), counter strain [13], and myofascial release (Meltzer, Cao et 
al. 2010).  
The following strain models and dimensions were used:  
1. Non-strain fibroblasts were grown on Bioflex membranes, but were not subjected to 
CSDS or ALDS. 
2. CSDS (cyclic short-duration stretches) modeled 8 hours of cyclic strain as would be 
experienced in a work day comprised of repetitive tasks such as a hammering. It was 
designed to exceed the strain modulus experienced from exercise and impose the 
phenotype of an overuse injury (Nakama, King et al. 2007).  Fibroblasts were grown on 
Bioflex membranes and cyclically strained to 10% beyond resting length at loading and 
unloading rates of 33% per second, and a frequency of 0.6 Hz for 8 hours.  
3. ALDS (acyclic long-duration stretch) was designed based on videomorphometric 
analyses of clinically applied myofascial release and compilations of elongation and rate 
of displacement (Meltzer, Cao et al. 2010). Since myofascial release typically lasts 60-
120 seconds, we selected a duration within this time frame. Fibroblasts were grown on 
Bioflex membranes and subjected to a single bout of acyclic strain that stretched cells 6% 
beyond their resting length at a loading rate of 3% per second. Strain was held for 60 
seconds before being released at a rate of 1.5% per second back to resting length.  
4. CSDS+ALDS (cyclic short-duration stretches combined with an acyclic long-duration 
stretch) combined our two strain paradigms to model patients suffering from repetitive 
motion strain injuries seeking treatment (Zainuddin, Newton et al. 2005). Fibroblasts were 
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subjected to a CSDS paradigm for 8 hours followed by a 3 hour static period.  They were 
then subjected to the ALDS paradigm for 60 seconds.  
Conditioned media cross-over 
Conditioned media from uniculture fibroblast wells (Figure 4B) were collected from all 
strain groups 24 hours post-strain and stored at -80°C. Thereafter we sought to determine if 
these conditioned media were capable of inducing differentiation in uniculture myoblasts (Figure 
4A). Media were replaced with fresh aliquots of fibroblast conditioned media every day for five 
days.  Untreated media (2% FBS in DMEM) served as a negative control. Three 
photomicrographs taken at 10X magnification (2.32 mm2 per high powered field) were obtained 
from myoblast wells after 48, 72, and 96 hours in conditioned media and assessed for 
differentiation (multinucleated cells with ≥ 3 nuclei). Three experiments each with three 
independent cell cultures were analyzed (N=9). 
Coculture system 
A novel coculture system was developed to allow for immediate interaction between 
soluble signaling molecules released by strained and unstrained fibroblasts and attendant non-
strained myoblasts. Our coculture was modeled after the myofascial junction as it exists in vivo. In 
two separate microenvironments, fibroblasts were seeded in Bioflex plates (25,000 cells/ml, 2% 
FBS) and skeletal myoblasts were seeded onto non-deformable glass coverslips (16,000 cells/ml, 
10% FBS). After 24 hours, the myoblast coverslips were transferred to the Bioflex plates 
containing fibroblasts. The orientation of the coverslips was such that the cell side faced the 
fibroblasts. Coverslips were custom made (Fisher Scientific, Houston, TX) to be fastened 
approximately 2 mm above Bioflex well membranes, allowing for fibroblasts but not myoblasts to 
be selectively strained (Figure 4C). Immediately after establishing the co-culture, fresh growth 
media (2% FBS in DMEM) was added and strain paradigms initiated. Media were not changed 
during the experiment, allowing strain-induced cytokines to remain in co-culture and within 
diffusible range of the proliferating myoblasts. We selected a 96 hour time point post-strain for 
myotube assessment since this duration produced sufficient differentiation without requiring 
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replacement of media (Figure 11). Uniculture myoblasts seeded on coverslips and placed into 
fibroblast-free Bioflex wells (Figure 4A) served as controls. At the end of each experiment, 
myotube coverslips were gently removed with sterile forceps and assessed for differentiation (see 
details below). Seven experiments each with three independent cell cultures per treatment were 
completed (N=21).  
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Figure 4. Uniculture and Coculture Systems in Bioflex Wells. Myoblasts (A, C) were seeded 
on non-deformable coverslips and situated two millimeters above Bioflex membranes. The 
orientation of the coverslips is such that the cell side faces the fibroblasts. Fibroblasts (B, C) 
were seeded on Bioflex membranes and subjected to mechanical strain paradigms as described.  
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IL-6 ELISA 
Fibroblast-derived IL-6 is up-regulated in response to mechanical strain and has 
documented roles in skeletal muscle differentiation (Skutek, Van Griensven et al. 2001; Serrano, 
Baeza-Raja et al. 2008). Therefore culture media from strained and non-strained groups were 
collected at three time points: 1) when our ALDS paradigm was applied 3 hrs post-CSDS, 2) 
when conditioned media was collected at 24 hrs post-strain, and 3) when myotube differentiation 
was assessed at 96 hrs post-strain. Media were analyzed for human IL-6 using DouSet ELISA 
kits (R&D Systems, Minneapolis, MN) according to the manufacturer protocol. The ELISA 
specifically detected IL-6 from human cells only, hence all IL-6 data from co-culture is fibroblast-
derived (N=9). 
Exogenous IL-6 in uniculture  
To test potential effects of IL-6 alone on myoblast differentiation, human recombinant IL-6 
(hrIL-6; R&D Systems, Minneapolis, MN) was added to uniculture myoblasts at incremental doses 
of 0.0, 0.10, 1.0, 10.0, and 100.0 ng/ml. Myoblasts were seeded (at 16,000 cells/ml, 10% FBS) 
and then allowed to acclimate for 24 hours after which time the media were replaced with 2% 
FBS supplemented with hrIL-6. Uniculture myoblasts remained in rhIL-6-containing media for 96 
hours after which differentiation was assessed microscopically. Four experiments each with 3 
independent cell cultures were completed (N=12). We also tested these IL-6 concentrations in co-
culture to determine if there were additive effects (N=4).  We verified that exogenous IL-6 was 
present at the conclusion of these experiments by measuring immunoreactive IL-6 via ELISA.  
Neutralization of IL-6 in co-culture 
 
To determine the potential role of IL-6 in fibroblast-mediated myoblast differentiation, an 
IL-6 antibody (ab6672, Abcam, Cambridge, MA) was used to neutralize IL-6 activity in co-culture. 
Based on a combination of manufacturer recommended dosing and our own preliminary 
experiments, 20 µg/ml of IL-6 antibody was used.  Media was supplemented with the IL-6 
antibody immediately upon establishing the co-culture followed by initiation of strain paradigms. 
Myoblast differentiation parameters (see below) were then analyzed 96 hours post-strain. As a 
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negative control, 20 µg/ml of heat inactivated rabbit serum (Abcam, ab7487) was added to 
untreated strain groups in co-culture. Two experiments each with three independent cell cultures 
(N=6) were completed. 
Imaging Analysis 
At the conclusion of each experiment, myoblast coverslips were fixed in Papfix (BBC 
Biochemical, Mt. Vernon, WA) and stained with hematoxlyin and eosin. Coverslips were mounted 
on pre-labeled microscope slides. Labels were then concealed and coded so that cells were 
imaged by blinded observer. A series of high powered field (HPF) images at 20X (0.58 mm2/HPF) 
were obtained using an Olympus IX-71 inverted microscope. Coded images were then assessed 
for myotube differentiation using three criteria: the number of myotubes per square millimeter (≥3 
nuclei/cell); the number of nuclei within each myotube; and fusion efficiency, a measure that 
calculates the number of nuclei contained within myotubes as a percentage of the entire 
population of myoblast and myotube nuclei (Figure 5). Myotubes with multiple branches were 
considered to be one large myotube when the cytoplasm was continuous. Myotubes that 
bordered the edge of an image were only counted if ≥3 nuclei were observed. Quantification of 
these large data sets was facilitated via CellProfiler (Broad Institute, Cambridge, MA). Utilizing 
this bioimaging software platform, we designed a unique algorithm to automatically quantify 
images of hematoxlyin stained nuclei to produce nuclei counts of 50,000 to 200,000 per 
experiment. 
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Figure 5. Images of C2C12 Skeletal Muscle in Uniculture (A) and Coculture (B) 96 Hours 
after Strain Profiles. Quantification of myotubes per square millimeter (1.7, 6.9), nuclei per 
myotube (3.0, 7.2), and fusion efficiency (1.1%, 6.7%) demonstrate fibroblast’s ability to induce 
myoblast differentiation. Examples of multinucleated myotubes are shown by arrows.  
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Statistical Test and Data Acquisition 
Replicate experiments, each with three independent cell cultures per treatment, were 
completed. Between 8 and 16 images were obtained per cell culture to acquire 72-180 images 
per treatment. Images for each cell culture were averaged and designated as N=1. Image data of 
all independent wells in a treatment group (N=9-21) were then combined in SPSS v.20 and 
analyzed for significance via  two-way analysis of variance with experiment and strain type as 
explanatory factors.  Tukey post-hoc tests were used for co-culture and ELISA experiments and 
Dunnett’s tests were used to compare IL-6 doses to vehicle, or strained conditioned media to 
non-strain conditioned media. A repeated measure ANOVA was used to analyze time-dependent 
myoblast differentiation for each conditioned media sample, and student t-tests were used for 
single comparisons between α-IL-6 treatments and their respective untreated group. Means were 
considered statistically significant if p<0.05. 
Results 
 
Fibroblast Media Cross Over 
We have previously shown fibroblasts secrete a diverse population of cytokines, and that 
CSDS up-regulates IL-1α, IL-1β, IL-2, IL-6, IL-1rα, IL-16, and NO. We have also reported that 
ALDS modifies fibroblast cytokine secretion induced by CSDS (Meltzer and Standley 2007). We 
used these same conditioned media to test for their abilities to induce myoblast differentiation. 
Conditioned media from all strain groups enhanced differentiation by 96 hours, p<0.05 (Figure 6). 
However, the degree to which differentiation occurred varied among strain groups. CSDS 
conditioned media produced a greater number of myotubes than non-strain conditioned media 
after 96 hours. However, when combine with ALDS, the conditioned media did not have an effect. 
These results demonstrate that fibroblast mediators in the conditioned media induce myoblast 
differentiation in a strain-dependent manner. 
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Figure 6: Myotube Densities in Fibroblast Conditioned Media after 48, 72, and 96 hours. 
Three experiments with three cell cultures per strain group (N=9) were combined. Symbols show: 
* > 48 hours, ψ > non-strain, p<0.05.                                                                           
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Co-culture  
In co-culture, the presence of fibroblasts in co-culture enhanced myotube numbers  by 
190% vs. uniculture, p<0.05 (Figure 7A). Resultant co-cultured myotubes also displayed a greater 
number of nuclei than those derived from uniculture, p<0.05 (Figure 7B).  We again observed that 
strained fibroblasts modify myoblast differentiation outcomes. Fibroblasts subjected to CSDS did 
not show a significant increase in myotube parameters vs. uniculture, suggesting an inhibitory 
role for CSDS in myoblast differentiation (Figure 7C). ALDS alone had no effect on any parameter 
of myoblast differentiation vs. non-strain co-culture. However when following CSDS, ALDS 
significantly increased myotube number by 78% and fusion efficiency by 96% vs. CSDS alone, 
suggesting a beneficial role for the combined CSDS+ALDS paradigm in myoblast differentiation. 
We seeded myoblasts on non-deformable coverslips above fibroblast-free Bioflex wells (Figure 
4A) and subjected them to strain paradigms to confirm that elastomeric strain and potential 
associated fluid currents did not influence myoblast differentiation. No differentiation was 
observed (Figure 11).  Neither myoblast nor fibroblast proliferation rates were significantly 
affected by strain or co-culture (Figure 4D and Figure 21, respectively).  
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Figure 7: Differentiation of Myotubes Grown in Coculture per square millimeter (A), nuclei 
per myotube (B), and fusion efficiency (C) were combined from seven experiments with three cell 
cultures per strain group (N=21). The black bars designate co-culture and white bars uniculture. 
Symbols show: * > uniculture, δ > RMS, p<0.05. 
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Interleukin-6 ELISA 
 
IL-6 secretion from fibroblasts was not significantly altered among uniculture or co-culture 
groups at 24 hours post-strain (Figure 8A). However after 96 hours, co-culture fibroblasts from 
the non-strain and  ALDS groups displayed a ten-fold increase in IL-6 secretion vs. uniculture 
fibroblasts, p<0.05 (Figure 8B).  We determined that all detectable IL-6 was secreted from the 
fibroblasts as the C2C12 myoblasts did not secrete human IL-6 as measured by our ELISA 
(Figure 22).  Surprisingly, CSDS and CSDS+ALDS co-culture groups did not display elevated IL-
6 secretion at 96 hours. Both groups were decreased compared to the ALDS only group (Figure 
8B, p<0.05). To determine whether IL-6 was up-regulated at the time of ALDS treatment, IL-6 
was measured 3 hours post CSDS. There was no change in IL-6 secretion vs. non-strain at this 
time point (Figure 8C).  
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Figure 8. Human IL-6 Secretion from Fibroblasts at (A) 3 hours, (B) 24 hours, and (C) 96 
hours post-strain. The black bars designate co-culture and white bars uniculture fibroblasts. 
Immunoreactive IL-6 was measured from three experiments with three cell cultures each (N=9). 
Symbols show: * > uniculture, δ > CSDS, ω > CSDS+ALDS, p<0.05. 
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Exogenous Interleukin-6 Addition 
 
Addition of hrIL-6 to uniculture myoblasts tested whether IL-6 alone could reproduce 
fibroblast-enhanced myoblast differentiation. Doses of exogenous hrIL-6 tested failed to induce 
parameters of myoblast differentiation (Figure 9).  At the time of analysis, myoblasts had reached 
confluence for all groups and myoblast proliferation was equal among all hrIL-6 doses and vehicle 
(Figure 9D). Preliminary experiments were also conducted in co-culture to test for additive effects 
of hrIL-6 in the presence of fibroblasts, yet again; no effects on myoblast differentiation were 
observed (Figure 23). To determine whether exogenous IL-6 was still present in media at the time 
of myotube analysis, we measured IL-6 via ELISA in all groups. Approximately 10% of the original 
exogenous IL-6 concentrations (0.10-100.0 ng/ml) were still detectable in all treatment groups 
(Figure 24).  
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Figure 9. Differentiation measures in the presents and absence of exogenous IL-6 doses 
(0-100 ng/ml) after 96 hours in uniculture. The vehicle was untreated media (2% FBS in DMEM). 
Data for myotubes per square millimeter (A), nuclei per myotube (B), fusion efficiency (C), and 
myoblasts per square millimeter (D) were combined from four experiments with three cell cultures 
per IL-6 dose (N=12). 
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Neutralizing IL-6 Antibody 
A neutralizing IL-6 antibody was added to co-culture to determine whether IL-6 was 
necessary for fibroblast-mediated myotube differentiation. All co-cultured groups treated with 20 
µg/ml IL-6 antibody and subjected to strain decreased myoblast differentiation by 47-65% vs. 
untreated co-culture strain groups, p<0.05 (Figure 10A). Fusion efficiency was also significantly 
reduced in all α-IL-6 treated strain groups by ~50-65%, but not in the non-strain group (Figure 
10C) suggesting that mechanical strain may be affecting myotube sensitivity to IL-6.  To ascertain 
whether IL-6 neutralization could also inhibit myoblast differentiation without fibroblasts present, 
we tested these same IL-6 antibody doses in myoblast unicultures in both growth media and 
differentiation media (Figure 25). The IL-6 antibody had no effect on myoblast differentiation 
suggesting that fibroblasts and their co-secretions are necessary for IL-6 action. 
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Figure 10: Differentiation Measures in Coculture Supplemented with 20 μg/ml Interleukin-6 
neutralizing antibody 96 hours post-strain. Data for myotubes per square millimeter (A), nuclei 
per myotube (B), and fusion efficiency (C)  were combined from two experiments with three cell 
cultures per treatment (N=6). Results were normalized to respective untreated co-culture strain 
group and shown as a percent change from untreated. Symbols show: * > greater than untreated 
co-culture, p<0.05.  
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Discussion 
Repetitive motion strain is associated with a number of degenerative musculoskeletal 
disorders including carpal tunnel syndrome, lower back pain, tension neck syndrome, rotator cuff 
syndrome, sciatica, epicondylitis, tendinitis, and carpet layer’s knee. These disorders frequently 
result in muscle fibrosis and atrophy (Barr and Barbe 2002). Manual manipulation is commonly 
used to treat these disorders (Valen and Foxworth ; Sakakima and Yoshida 2003; Sucher, 
Hinrichs et al. 2005); however, cell-based studies evaluating the efficacy of treatment are still 
warranted. We therefore investigated the effects of applying a modeled repetitive motion strain, 
by inducing cyclic short-duration stretches (CSDS), and a modeled myofascial release, by 
inducing an acyclic long-duration stretch (ALDS), to fibroblasts on mediating skeletal muscle 
differentiation.  
Our results support the idea that fibroblasts regulate skeletal muscle differentiation 
through paracrine actions of secreted mediators. We experimentally determined that both 
fibroblast conditioned media and fibroblasts in co-culture were capable of stimulating myoblast 
differentiation.  These data are supported by other researchers that concluded myotubes grown 
on a fibroblast feeder layer survived longer and displayed enhanced contractile activity. The 
authors attributed these results in part to unidentified secreted growth factors that assisted in the 
myotube development (Cooper, Maxwell et al. 2004). Another study concluded that fibroblasts 
from bovine muscle  secreted a soluble myoblast growth factor in conditioned media that 
increased myoblast proliferation and fusion to myotubes (Quinn, Ong et al. 1990). These 
researchers sought to identify a potential growth factor mediating this process, and determined it 
was neither bFGF nor IGF-1. They further noted myotrophic activity only occurred when 
fibroblasts were proliferating. It was recently demonstrated that fibrogenic/adipogenic progenitor 
cells (FAPs) obtained from murine hind limbs represent an inducible-source of IL-6. When 
induced to proliferate, FAPs not only secreted IL-6, but also facilitated myoblast fusion efficiency 
(Joe, Yi et al. 2010).   
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IL-6 is a known stimulator of muscle growth and differentiation (Pedersen and Febbraio 
2008; Serrano, Baeza-Raja et al. 2008), and is secreted by fibroblasts in a strain-dependent 
manner (Skutek, Van Griensven et al. 2001; Eagan, Meltzer et al. 2007). We therefore sought to 
identify whether increased myoblast differentiation caused by the presence of fibroblasts in co-
culture was due to fibroblast-derived IL-6. We showed that human fibroblast IL-6 secretion 
increases by ten-fold when in co-culture (Figure 5B). This suggests that the C2C12 myoblasts 
likely influence the secretory behavior of fibroblasts. Similarly, other research has shown that 
fibroblast IL-6 secretion increases one hundred-fold in the presence of T-Cells (Sporri, Bickel et 
al. 1996) leading to the speculation that cellular cooperation between fibroblasts and other cell 
types could be a powerful mediator of the inflammatory response and wound healing. These IL-6 
data correlate well with our finding that fibroblasts induced myoblast differentiation when in co-
culture. For the first time, we also showed that fibroblasts directly regulate skeletal muscle 
differentiation through soluble IL-6. When IL-6 was neutralized in co-culture myoblast 
differentiation was inhibited (Figure 10). However, exogenous IL-6 alone could not induce 
differentiation (Figure 6), indicating that IL-6 is necessary but not sufficient for myoblast 
differentiation. We speculate that fibroblasts and their co-secretions are required in addition to IL-
6 for myoblast differentiation. While mechanical strain regulates many fibroblast-derived 
cytokines, it could not rescue the inhibitory effects of IL-6 neutralization (Figure 10).  At the time 
of myotube analysis we did not measure a change in myoblast number in response to exogenous 
IL-6 doses, although others have shown that C2C12s over-expressing IL-6 increase proliferation 
[32]. It is likely that the time of analysis or the constitutive over-expression of IL-6 in transfected 
cells versus a single additive dose used in our model account for this disparity. 
We demonstrated that myoblast differentiation can be differentially regulated by 
conditioned media of mechanically strained fibroblasts (Figure 6) and by strained fibroblasts in 
co-culture (Figure 7). Interestingly, these two experimental approaches uniquely regulated 
differentiation outcomes. For instance, conditioned media from fibroblasts subjected to CSDS 
produced the greatest number of myotubes, but in co-culture CSDS treatment resulted in the 
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least myotube differentiation among groups. Previously, we have shown CSDS conditioned 
media is a rich source of cytokines twenty four hours post-strain (Meltzer and Standley 2007), 
and that myotube differentiation is also intensified from this CSDS conditioned media may 
suggest differentiation-favorable cytokines are temporally up-regulated by fibroblasts and strain. 
The co-culture system we designed ensured that myoblasts were exposed to fibroblast cytokines 
at all stages pre- and post-strain. CSDS inhibited myotube differentiation in co-culture, which may 
suggest that at a later time point the secretion of an inhibitory molecule occurs in the RMS 
paradigm. Contrasting with these data, CSDS+ALDS treatment in co-culture significantly 
enhanced myotube differentiation and reversed the deleterious effects brought on by CSDS 
alone. Notably, we reported that ALDS down-regulates several CSDS-induced cytokines 24 hours 
post-strain (Meltzer and Standley 2007). Together these data suggest that CSDS-induced 
cytokines which regulate myoblast differentiation are also regulated by the subsequent ALDS 
treatment.  
The increased number myotubes resulting from the CSDS+ALDS paradigm shows that a 
single sustained slow-loading strain has profound impact on myoblast differentiation. If clinically 
translatable, restorative strain regimens such as myofascial release applied to a fibroblast-rich 
tissue following injury may facilitate muscle repair.  While ours is the first study to measure the in 
vitro effects of mechanical strain and fibroblasts on myoblast differentiation, others have shown 
beneficial effects of slow-loading strains on skeletal muscle. For instance, chronic static stretching 
after exercise has been shown to increase knee flexion and extension repetition maximums 
(Kokkonen, Nelson et al. 2007). The authors proposed that increased muscle strength is the most 
likely mechanism of this effect as evidence by several studies of stretch-induced muscle 
hypertrophy (Stauber, Miller et al. 1994). Other studies have used external fixator devices to 
lengthen rabbit limb tibiae 1 mm/day for 10 days. The muscle lengthening consequently induced 
satellite cells to activate and fuse to generate de novo skeletal muscle (Day, Moreland et al. 
1997; Tsujimura, Kinoshita et al. 2006). The muscle fasciae close anatomical interaction with the 
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skeletal muscle, and similar exposure to mechanical loads during strain, may help to explain a 
mechanism for increased muscle during these processes.  
Biomechanical strain affects fibroblast mechanoreceptors such as integrin-cytoskeletal 
connections to activate several signaling pathways: MAPK, SAPK, NF-KB, and EGR which then 
influence cytokine secretion (Copland and Post 2007). Upon mechanical stimulation, the p38 
pathway is activated which subsequently up-regulates IL-6 secretion (Pedersen, Steensberg et al. 
2001). Surprisingly, our data did not show increased IL-6 in any group 24 hours post-strain 
(Figure 5A), and revealed CSDS and CSDS+ALDS attenuated fibroblast IL-6 secretion 96 hours 
post-strain (Figure 8B). We speculate that other cytokines are likely involved in the skeletal 
muscle differentiation process and co-regulate IL-6 secretion and we have designed experiments 
to test this. Strain-regulated cytokines may also affect the sensitivity of skeletal muscle to IL-6 by 
regulating IL-6 receptor expression, downstream intracellular proteins, or other means; however 
this study did not investigate those pathways. 
While repetitive motion strain and clinical  myofascial release direct mechanical forces to 
fascia fibroblasts, indirect strains applied to nerves, blood vessels, the lymphatic system, and pre-
existing muscles (Toumi, F'guyer et al. 2006) are not considered in our model. Pre-existing 
muscles also greatly contribute to the muscle repair process by undergoing hypertrophy or fusing 
with adjacent myotubes; however, we were uniquely interested in the effects of stretched 
fibroblasts on myoblast differentiation and therefore did not make these measurements in the 
present study.  We therefore do not want to overreach on interpretations of these data, and 
support the future use of these strain paradigms and analysis parameters in animal and human 
models to validate our findings. Our simple system allows soluble signaling molecules to interact 
in an in vitro environment modeled after a simple myofascial junction to investigate direct 
interactions between two cell types.  Despite the limitations of in vitro modeling, data from our 
laboratory suggest that cultured human fibroblasts adapt specifically to mechanical loading in 
manners dependent upon strain magnitude, duration, and frequency. The unique response of 
fibroblasts to mechanical strain and consequent effects on myoblast differentiation should be 
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further investigated to optimize strain protocols to best facilitate skeletal muscle repair. Our 
cellular strain models may prove useful in further investigation of mechanisms germane to muscle 
injury, as well as help to build a cellular evidence base describing the positive outcomes of 
applied manual treatments in the clinical setting. 
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CHAPTER 3. FIBROBLASTS AND STRAIN REGULATE SKELETAL MYOTUBE 
CONTRACTION, NICOTINIC ACETYLCHOLINE RECEPTOR EXPRESSION AND CLUSTER 
REMODELING  
Abstract 
Skeletal muscle functionality is governed by multiple stimuli including cytokines and 
biomechanical strain. Fibroblasts embedded within muscle connective tissue respond to 
biomechanical strain by secreting cytokines that induce myoblast differentiation and we 
hypothesize regulate myotube function. A coculture was established to allow crosstalk between 
fibroblasts in Bioflex wells, and myoblasts on non-deformable coverslips situated above Bioflex 
wells. Cyclic-short duration strain (CSDS) modeling repetitive stress/injury, acyclic long-duration 
strain (ALDS) modeling manipulative therapy, and combined strain paradigms (CSDS+ALDS) 
were applied to fibroblasts. Non-strained myoblasts in uniculture and coculture served as 
controls. After fibroblasts had induced myoblast differentiation, myotube contraction was 
assessed by perfusion of ACh[10-11-10-3M] and KCl[10-2M]. CSDS-fibroblasts increased myotube 
contractile sensitivity versus uniculture (P<0.05). As contraction is dependent upon ACh binding, 
expression and clustering of nicotinic receptors (nAChRs) were measured. CSDS-fibroblasts 
increased nAChR expression (P<0.05) which correlated with myotube contraction. ALDS-
fibroblast did not significantly affect contraction nor nAChR expression. Agrin-treated myotubes 
were then used to design a computer algorithm to identify αBGT-stained nAChR clusters. ALDS-
fibroblasts increased nAChR clustering (P<0.05); while CSDS-fibroblasts disrupted clusters from 
forming. CSDS-fibroblasts produced nAChRs preferentially located in microclustered regions 
(P<0.05). Strain-activated fibroblasts mediate myotube differentiation with multiple functional 
phenotypes. Similar to muscle injury, CSDS-fibroblasts disrupted nAChR clusters and 
hypersensitized myotube contraction, while ALDS-fibroblasts aggregated nAChRs in large 
macroclusters which may have important clinical implications. Cellular strategies aimed at 
improving muscle functionality, such as through biomechanical strain vehicles that activate 
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fibroblasts to stabilize neuromuscular junctions on nearby skeletal muscle may serve as novel 
targets in neuromuscular disorders.  
Introduction 
The long-term goal for muscle regeneration strategies is to recover the functional 
properties of injured muscle. Given that 6 million Americans are diagnosed with musculoskeletal 
diseases each year, the potential to improve muscle regeneration and drive regeneration to 
completion is significant (Borselli, Storrie et al. 2010). Essential to muscle regeneration are 
satellite cells residing beneath the basal lamina of each myofiber. After injury, quiescent satellite 
cells are activated to form a proliferative pool of myoblasts that differentiate and fuse to provide 
myonuclei required for repair or replacement of damaged myofibers (Collins, Olsen et al. 2005). 
Myotube differentiation and synthesis of proteins regulating functional outcomes are dependent 
upon inputs from cytokines and growth factors including IGF-1, HGF, IL-6, TNFα, myostatin, and 
others derived from the cellular milieu (Charge and Rudnicki 2004). 
Once functionally mature, myotubes express and maintain nicotinic acetylcholine 
receptors (nAChRs) that mediate contraction through ligand-binding voltage-gated Na+ channels. 
Plasticity of nAChRs clustered at the motor endplate in the context of cluster size, shape, and 
density is important for muscle homeostasis and function (Deschenes 2011). Nowhere are the 
functional roles of nAChRs more apparent than myasthenia gravis, an autoimmune disease that 
degrades nAChRs, and results in impaired synaptic transmission and life-threatening muscle 
weakness (Vincent 2002). Synaptic dysfunction also occurs during advanced aging and is a 
major contributor to neurodegenerative diseases such as amyotrophic lateral sclerosis. 
(Deschenes, Judelson et al. 2000). On the other end of the clinical spectrum, physical activity 
increases the total postsynaptic area and functional plasticity of healthy skeletal muscle that may 
improve motor function for athletes and physical rehabilitation patients (Hewett, Zazulak et al. 
2005). Thus strategies aimed at promoting functional regeneration of muscle are timely for 
several demographies. 
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Fibroblasts comprise more than 50% of the extramuscular cell populations 
interpenetrating skeletal muscle (Flavell, Hou et al. 2008) and are a major cellular component of 
regenerating muscle, ensuring effective and efficient repair (Murphy, Lawson et al. 2011). 
Fibroblasts also synthesize a unifying connective tissue to meet the biophysical demands of 
dynamically functioning muscle, and can respond to mechanical stimuli within minutes (Vogel and 
Sheetz 2006). Thus, fibroblasts serve as sensitive mechanotransducers by modifying expression 
of extracellular matrix proteins and secreting cytokines that may act on nearby muscle. We and 
others have shown different versions of mechanical strain can uniquely influence fibroblast 
behavior and their resulting secretions.  Therefore, biomechanical strain may serve as a vehicle 
directing fibroblasts to mediate skeletal muscle behavior. Empirical evidence in support of this 
concept shows that bouts of one minute stretching can reorganize fibroblast-rich connective 
tissue and induce muscle hypertrophy (Coutinho, Deluca et al. 2006) that has synergistic effects 
on strength gains and muscle activation (Kokkonen, Nelson et al. 2010); whereas repetitive tasks 
that result in excessive use of skeletal muscle and its surrounding fascia can cause fibroblast-
mediated inflammation, strain-induced injury, and dystonia (Kietrys, Barr et al. 2011). Fibroblasts 
are known to serve dual roles in muscle regeneration by augmenting the repair process, or 
synthesizing fibrotic and inflammatory molecules that inhibit muscle regeneration (Serrano and 
Munoz-Canoves 2010). Thus understanding the mechanisms by which biomechanical strain 
influences the phenotypic shift of fibroblasts towards promoting functional regeneration of muscle 
is of clinical significance.  
Our lab has previously developed methods to mechanically strain fibroblasts seeded on 
flexible membranes (Meltzer, Cao et al. 2010). Using a clinically relavent stretch treatment as a 
reference, an acyclic long-duration strain (ALDS) regimen was modeled after myofascial release, 
a form of manipulative treatment which applies sustained force to fibroblast-rich tissues to release 
restriction points (Ramsey 1997). By analyzing video recordings of manual clinicians performing 
myofascial release we determined the strain magnitude and duration required to develop an in 
vitro model. We have shown a single ALDS treatment has significant effects on fibroblast 
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secretions including: angiogenin, granulocyte colony-stimulating factor, thymus and activation-
regulated chemokine, IL-1β, IL3, and IL8 (Cao, Hicks et al. 2013). We also developed a cyclic-
short duration strain (CSDS) regimen to induce a stress injury response in the fibroblasts, and 
combined strain regimens (CSDS+ALDS) to model a repetitive strain injury followed by a 
manipulative treatment as might typically be experienced clinically. 
Using these models we built a fibroblast-skeletal muscle coculture and demonstrated that 
strain-activated fibroblasts significantly enhance myoblast differentiation through Interleukin-6 
(Hicks, Cao et al. 2012). The current study extends our previous work by investigating the 
functional phenotype of myotubes differentiated in the presence of strain-activated fibroblasts. We 
hypothesized that fibroblasts subjected to specific variations of strain magnitude, duration, and 
frequency could modify the contraction of nearby myotubes, and contraction would correlate with 
fibroblast-directed changes to nAChR expression and clustering. We developed a novel method 
to investigate in vitro myotube contraction in response to incremental acetylcholine doses. While 
others have used electric pulse stimulation to quantify skeletal myotube contraction in vitro 
(Langhammer, Zahn et al. 2010), our approach allowed for a more direct correlation of nAChR 
expression and clustering in myotube populations. We also used quantitative fluorescent imaging 
to measure nAChR clusters based on previous studies (Akkaboune, Culican et al. 1999), and 
show strained and non-strained fibroblasts are capable of regulating the phenotypic outcomes of 
myotubes. Thus fibroblasts may serve as a novel therapeutic target for strategies aimed at 
facilitating muscle regeneration. 
Methods 
Coculture setup and applied biomechanical strain to fibroblasts 
A coculture was established to allow paracrine interactions between fibroblasts (NHDF, 
Cambrex Laboratories) and myoblasts (C2C12, American Tissue Culture Collections). Fibroblasts 
were seeded (6.5x104 cells/cm2, 2% FBS) in 35 millimeter Bioflex wells which contain an 
elastomeric surface membrane allowing adherent cells to deform under vacuum (BF3001-C, 
Flexcell International Corp). Myoblasts were seeded (4.1x104 cells/cm2, 10% FBS) on 34x13 
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millimeter non-deformable glass coverslips custom-made to be affixed 2 millimeters above the 
Bioflex wells in an arrangement that allowed fibroblasts, but not myoblasts, to be mechanically 
strained (Figure 1A). Cell cultures were kept at 5% CO2, 37°C in all experiments. DMEM 
(#11885076, Life Technologies) served as a basal media for fetal bovine and horse serums.  
After 24 hours, coverslips containing myoblasts were transferred to Bioflex wells 
containing fibroblasts, and orientated such that the myoblasts faced the fibroblasts. The 
coverslips and Bioflex well dimensions allowed for 5.2 cm2 of gas exchange per 9.6 cm2 surface 
area. Immediately after establishing the coculture, fresh growth media (2% FBS in DMEM) was 
added and strain regimens initiated. The Flexcell FX-4000 Tension Plus System (Flexcell 
International Corp, Hillsborough, NC) is a computer-controlled device designed to deliver 
negative-pressure vacuum through user programming of strain magnitude, duration, and 
frequency. Bioflex membranes were strained equiradially using four protocols as described 
previously (Meltzer, Cao et al. 2010; Hicks, Cao et al. 2012):   
Non-strain: fibroblasts were grown on Bioflex membranes, but were not subjected to 
strain.  
Acyclic long-duration strain (ALDS): fibroblasts grown on Bioflex membranes were 
subjected to a single acyclic strain. Membranes were elongated 3%/sec until 6% beyond 
resting length was reached. Strain was held for 60 seconds and returned to baseline at 
1.5%/sec. 
Cyclic short-duration strain (CSDS): fibroblasts grown on Bioflex membranes were 
cyclically strained at 0.6 Hz for 8 hours. Membranes were elongated 33%/sec until 10% 
beyond resting length was reached then immediately returned to baseline at 33%/sec. 
There is a 1 second rest phase between the end of one cycle to the beginning of the next 
thus a complete cycle last approximately 1.6 seconds.   
Cyclic short-duration strain combined with acyclic long-duration strain 
(CSDS+ALDS): Fibroblasts on Bioflex membranes were subjected to a CSDS protocol 
followed by a 3 hours rest period. They were then subjected to the ALDS protocol.  
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Following strain regimens, cells remained in cocultures without media change for 96 hours to allow 
secreted mediators from strain-activated fibroblast to induce myotube differentiation as we have 
previously reported (Hicks, Cao et al. 2012). myotubes were then assessed for myotube 
differentiation parameters and resulting functional phenotypes (see details below).  
Measurements of strain-induced fluid forces on myoblast viability and myotube 
differentiation in the presence and absence of fibroblasts.  
To test whether myotubes exposed to the strain environment were affected by fluid forces 
and media agitation, C2C12 cells in non-fibroblast strain experiments were analyzed for 
proliferation, differenation, and viability at 3, 48, and 96 hours post-strain (Figure 11). Myoblast 
proliferation was measured by counting DAPI-labeled nuclei per millimeter squared; myotube 
differentiation was measured by counting cells expressing myosin with ≥3 nuclei per cell; and the 
fusion index was calculated as the percentage of nuclei in myotubes to the entire C2C12 
population. Because C2C12 cells are highly metabolically active, and 96 hours without media 
change could potentially impact cell viability, extracellular DNA produced as a result of cell death 
was assayed from conditioned media. Manufacturer-recommended culture conditions for C2C12 
cells that include a 24 hour media change, and a starting seeding density of 13.3x104 cells/ml in 
10% FBS was used as for comparison. Data are presented in raw fluorescent units per culture 
well (RFU/well; Promega, G8742). Trypan blue exclusion was also performed for all time points 
and treatments (Figure 28, Appendix). While we previously analyzed myotube differentiation for 
all strained coculture groups (Hicks, Cao et al. 2012),  this set of experiments exposed C2C12 
cells in unicultures and cocultures to only the cyclic short-duration strain (CSDS) and non-strain 
paradigms to extend our previous work on the effects of non-fibroblast stretch experiments. We 
included a 3 hour post-CSDS time point, when ALDS would be applied in the CSDS+ALDS 
paradigm, and a 48 hour time point, half-way through the experiments, to measure whether there 
were immediate effects on myoblast proliferation and cell viability. Five independent cell culture 
wells were analyzed (N=5, see statistics section).  
Myotube contraction studies 
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A perfusion system was engineered to induce in vitro myotube contraction and test the 
functional capacity of myotubes differentiated in fibroblast cocultures. Coverslips containing 
myotubes were removed from cocultures and outfitted in 6-well perfusion plates with attached in-
flow and out-flow tubing holders. The apparatus allowed for continuous superfusion of myotubes 
with various contractile agonists and wash buffers. The superfascial velocity of perfusate, 
controlled by two variable-flow peristaltic pumps (Fisher Scientific, 138761), was delivered at 
47.6mm/min to myotubes on glass coverslips placed in 35mm perfusion plate wells. Out-flow 
tubing was situated 3mm above the in-flow tubing to assure constant submersion of myotubes 
with perfusate. Perfusion plates were positioned on an IX71 Olympus inverted microscope stage 
that monitored perfusions by video microscopy capturing 29 frames/sec. High powered fields 
(HPFs) with at least three myotubes were randomly selected for perfusion. Myotubes were 
defined as syncytial cells with ≥3 nuclei (Hicks, Cao et al. 2012).  
Myotubes were sequentially perfused for 1 minute with log10 increments of acetylcholine 
[ACh, 10-11-10-3 M] followed by KCl [10-3 M] to depolarize the myotube sarcolemma independently 
of nAChR activation. Myotubes were washed with 1X PBS for 1 minute between perfusions to 
remove previous ACh.  All perfusates were isosmotic and kept at 37°C, 7.4 pH to negate the 
effects of osmolality, temperature, and pH on myotube contraction. The perfusion plate was 
placed on a transparent 37°C thermoplate stage-top incubator (Tokai Hit, MATS-U55R30) during 
video capture for additional temperature control.  
To separate media and perfusion related changes from ACh-specific effects relating to 
progressive decreases in myotube area, we performed additional experiments which perfused 
myotubes differentiated in the presence of non-strain fibroblasts with one of four perfusates. 
Perfusate groups included: PBS-only; PBS containing ACh [1-11-1-3]M; PBS containing ACh [1-11-
1-3]M and 1.8mM Ca2+;  and PBS containing ACh [1-11-1-3]M perfused in myotubes treated with 
unconjugated α-bungarotoxin (αBGT; ab120542, Abcam). Myotubes treated with αBGT were then 
immediately transferred to our perfusion apparatus and administered ACh (Figure 14A). 
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Sequential videos of ACh- and KCl-induced myotube contractions were analyzed with 
Adobe Premiere Pro 5.0. The last still-frame from each perfusion video was extracted and images 
input into ImageJ for analyses. For length shortening experiments ten random coordinate points 
were identified on each myotube and measured using ImageJ. Alternatively, sarcolemma 
perimeters (Figure 13A, shown in phase contrast model) were carefully outlined and 
computationally filled to produce binary images representative of myotube areas on a blank 
canvas. To avoid potential bias all fully visible myotubes per field were outlined except those 
which overlapped each other in manners that could potentially influence contraction. Binary 
myotube images were then exported to ImageJ and myotube areas were measured. All myotubes 
per HPF video were analyzed as a percentage contraction from their own precontractile state. 
ACh-induced myotube contraction is reported as the percentage of fractional shortening from a 
precontracted value of 100%. Maximum fractional shortening in response to ACh, half-maximum 
effective dose 50% (ED50) and Hill slope, a measure describing the fraction of nAChRs bound by 
ACh, were calculated (see statistics). The R2 value quantifies the Hill slope goodness of fit.  
Myotube contraction values from each HPF were then averaged from one HPF video, N=1. A 
total of 12 perfusion experiments (corresponding to 105-140 myotubes) were performed for each 
treatment, N=12.   
Quantification of acetylcholine receptors by Western blot  
To measure nAChR expression, myotubes were removed from coverslips using a cell 
scraper and lysis buffer (Sigma, P8340). Three coverslips per treatment were pooled to acquire 
sufficient protein (50µg/lane).  Samples were sonicated and proteins separated on 4-20% Tris-
HCl gels in a Mini-Protean II Electrophoresis Cell (Biorad). Samples were transferred to 
nitrocellulose membranes and probed for AChR and GAPDH (Santa Cruz Biotechnology, sc-
14000 and sc-25778). Secondary antibodies (Licor, 926-32211) were used to detect protein 
expression by fluorescent densitometry using the Licor Odyssey Infrared Imager. Protein 
expression from Western blot was calculated using relative quantification from fluorescent 
densitometry data generated by Licor Odyssey software. Myoblasts in uniculture, seeded on 
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coverslips and transferred to Bioflex wells devoid of fibroblasts (2% FBS) served as a negative 
control. Treatment results were expressed as fold-change from uniculture, and normalized to 
endogenous control GAPDH. Seven independent samples (21 pooled wells) were analyzed per 
treatment, N=7.   
Identification of acetylcholine receptor clusters 
NAChRs present on differentiated myotubes were fluorescently labeled with 
tetramethylrhodamine α-bungarotoxin (αBGT, Molecular Probes, T1175) and quantitative 
fluorescent imaging was performed using an open-source software package in CellProfiler (Broad 
Institute). The automated image cytometry system identifies and measures objects’ size, shape, 
pixel intensity and topology, and resulting acquired data is contrasted against a background 
subtraction algorithm (Carpenter, Jones et al. 2006). Settings to identify nAChR clusters in 
CellProfiler were established using agrin-treated myotubes (16hr 1μg/ml rAg; R&D Systems, 550-
AG100) grown in differentiation media (DM; 2% horse serum, American Tissue Culture 
Collections). Agrin, normally secreted by α-motoneurons, stabilizes and aggregates nAChRs into 
distinguishable macrocluster regions (≥65% intensity), whereas outside these regions nAChRs 
largely exist in dispersed microclusters (<65% intensity) denoted by lower intensity pixels as 
described by others (Englander and Rubin 1987; Akaaboune, Culican et al. 1999). Myotubes from 
coculture experiments were incubated with 1 μg/ml αBGT for 30 minutes; coverslips containing 
myotubes were removed from coculture, fixed with 2% formaldehyde, and mounted on pre-
labeled microscope slides in DAPI-Vectashield (Sigma, H1200). Treatment identification labels 
were concealed and coded, and treatments were imaged by a blinded observer. Twelve images 
were obtained at 20X (0.58 mm2/HPF) for each independent cell culture. Microscope settings for 
intensity, exposure time, and staining techniques were stringently controlled to keep fluorescence 
consistency over the months αBGT experiments were conducted. To further account for variance 
in fluorescent intensity, data were analyzed using two-factor ANOVA with date of staining and 
treatment group as independent variables. 12 randomly and blindly selected myotubes from each 
independent cell culture were analyzed by CellProfiler.  In this manner, nAChR cluster data were 
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obtained for individual myotubes (108 myotubes/treatment, N=9). To further investigate if strain-
activated fibroblasts remodeled α-BGT stained regions, a histogram was created that quantified 
the size distribution of macroclusters, 4-1024µm2.   
Statistical analysis  
Data were analyzed using one-factor ANOVA with posthoc Tukey tests and P < 0.05 was 
used to test significance unless specifically noted. For cytotoxicity studies, a posthoc Dunnett test 
was used to compare treatment groups to the manufacture recommended culture conditions, P < 
0.05. For contraction studies, a total of 12 dose-response contraction videos from coculture and 
uniculture were taken for contractile analyses. Contraction data were input into GraphPad PRISM 
5.0 and ACh concentrations converted to Log base 10. A four parameter logistics sigmoidal dose-
response with variable slope was then used to determine logED50, Hill slope, and maximum 
response for each treatment. A precontractile value of 100% was assigned to all groups. 
Frequency distribution of AChR macroclusters were analyzed with Microsoft Excel. Histogram 
size brackets were fixed on log base 2 as surface area of the receptors (µm2) increases 
logarithmically. Student t-tests were used to analyze the effects of agrin-treated and untreated 
myotubes grown in differentiation media, P < 0.05. Data were correlated by plotting the combined 
mean ± SEM derived from each experimental procedure for each uniculture and coculture group, 
respectively. Linear regression analysis was used to calculate R2. Myotubes from DM and 
coculture were not compared as differences in media supplementation, seeding densities, and 
culture time may have confounding effects on analyses. All figures were made using GraphPad 
PRISM 5.0. 
Results 
Fibroblasts are necessary for myoblast differentiation 
Fibroblast-myoblast coculture conditions were carefully optimized to allow myotube 
differentiation to occur without needing to replace the fibroblast-conditioned media and minimizing 
cell death. Myotube differentiation was not observed at 3 or 48 hours post-strain in any treatment, 
suggesting the relatively low fusion index measured at 96 hours (~10% coculture and ~1% 
54 
uniculture) were products of recent differentiation and not a continuously renewing pool of 
immature myotubes. The low C2C12 seeding density and reduced serum concentration are likely 
contributors of these results. Importantly, fibroblasts significantly increased myoblast 
differentiation and fusion index versus uniculture at 96 hours post-strain (P < 0.05, Figure 11 P 
and Q). Myoblast proliferation was not affected by different treatments.  In the absence of 
fibroblasts, CSDS increased myoblast death at 96 hours, however this was not observed in 
coculture (Figure 11R). We speculate fibroblasts contribute minimally to cytotoxicity and secrete 
factors that may attenuate cytotoxic effects associated with C2C12 metabolic load. The 
application of CSDS to empty Bioflex wells, or CSDS to fibroblast-containing Bioflex wells, did not 
significantly affect differentiation outcomes versus non-strain counterparts showing that fluid 
forces alone could not induce differentiation. We stopped using CSDS in experiments absent 
fibroblasts in subsequent experiments. In a separate study we also measured myogenin, an early 
marker of myotube differentiation, (Qiagen, QT00112378) by rtPCR. Myogenin expression 
increased in non-strain cocultures by 8.8-fold and in CSDS coculture by 13.3-fold versus 
uniculture 24 hours post-strain; N=9, P < 0.05 (Figure 27, Appendix). Combined with our 
laboratories previous findings, these data served as a basis for investigating the functional 
phenotype of the resulting myotubes grown in the presence of fibroblasts. 
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R     Uniculture   Coculture 
Cytotoxicity (RFU/Well) Non-strain CSDS Non-strain CSDS 
96 hours post-strain 2107 ± 55.7 2236 ± 309.6γ 1646 ± 169.8 1796 ± 92.0 
Standard culture 
conditions 
    1469 ± 67.0  
 
 
Figure 11. Effects of Fibroblasts and Mechanical Strain on Myoblast Differentiation. 
Myoblasts on non-deformable cover glass were situated two millimeters above deformable Bioflex 
membranes containing fibroblasts (A-B). Myoblasts in non-strain uniculture (C-E), non-strain 
coculture (F-H), CSDS uniculture (I-K), and CSDS coculture (L-N) were fluorescently probed for 
actin (red), myosin (green), and myonuclei (blue). Myoblasts proliferation, myotube differentiation, 
and fusion efficiency were quantified (O-Q); * > uniculture, P < 0.05. Resulting cytotoxicity from 
mechanical strain, coculture, and 96 hours without media change were compared to the 
manufacturer recommended culture conditions: myoblasts seeded at 13.3x104 cells/cm2 with 24 
hour media change (R); γ > standard culture conditions, P < 0.05. 
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Length measurements of intracellular myotube organelles show a contraction-relaxation 
like response to acetylcholine  
Myotube length measurements identified shortening of intracellular structures in response 
to low doses of ACh that returned to their original resting length during PBS wash, suggesting 
contraction-relaxation occurred in myotubes (Line segment 5, Figure 12A-C). Subsequent higher 
doses of ACh resulted in partial loss of cell adhesion of the myotube, depicted by the 50% 
decrease length (Line segments 1 and 4, Figure 12D). However, other coordinates on the same 
the myotube did not change position (Line segments 2 and 3, Figure 12D). Thus measurements 
of myotube length produced variable results depending on the placement of the line segment 
making it impossible to reproducibly measure changes between myotubes. 
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A. Precontraction             B. 1 µM [ACh]                  C. PBS Wash      D. 1 mM [ACh] 
     
 
E. 
Table 1: Coordinates of myotube positions to measure length changes 
 Precontraction 1µM [ACh] PBS Wash 1mM [ACh] 
Line 
Segments 
Start 
(X, Y) 
End 
(X,Y) 
Start 
(X, Y) 
End 
(X,Y) 
Start 
(X, Y) 
End 
(X,Y) 
Start 
(X, Y) 
End 
(X,Y) 
1. 24, 502         258, 190 23, 501        257, 191 24, 502          258, 192 24, 501         160, 330 
2. 20, 500           42, 16 22, 500          40, 17 21, 500            39, 16 20, 499           39, 16 
3. 43, 429           53, 136       44, 425          52, 136 42, 426            49, 135 39, 16             39, 425 
4. 57, 393         156, 288  57, 390       154, 289 55, 391          152, 289 51, 134           49, 390 
5. 69, 348           69, 263 69, 345          70, 268 67, 350           68, 267 58, 355           59, 268 
  
 
Figure 12. Myotube Contraction and 
Relaxation in Response to ACh and PBS. 
Sequential images show a C2C12 myotube 
at precontraction (A), after 1µM ACh 
perfusion (B), PBS wash (C), and 1mM ACh 
(D). Ten coordinate points on the myotube 
were identified to measured changes in 
myotube length before and after perfusions 
(E). Coordinate points were selected at the 
left and right edges of the myotube (End-
End), and at myonuclei identified by their 
dark chromatin structures in the left, right, 
and center of the myotube (Nuclei-Nuclei). 
ImageJ was then used to create line 
segments 1-5. The graph plots the changes 
in line segment length (F). 
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Due to the variability in ACh-induced length shortening, the total area of the myotube was 
measured (Figure 13). However, the contraction-relaxation of intracellular structures identified by 
line segment shortening could not be ascertained when measuring changes in myotube area. 
Therefore, ACh-induced loss of cell adhesion was used as a surrogate for myotube contraction. 
Importantly, we show that increased doses of ACh resulted in progressive decreases in myotube 
area consistently measurable across all treatment groups. 
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A. Precontraction   B. 1 µM [ACh]                  C. PBS Wash      D. 1 mM [ACh] 
       
 
 E.      Myotube area change in response to ACh and PBS wash 
 Precontraction 1µM [ACh] PBS Wash 1mM [ACh] 
Myotube Area (µm2) 10,492 10,319 10,135 8,082 
Change from 
Original Resting 
Area 
100% 98.4% 96.6% 77.0% 
 
 
Figure 13. Area of Myotube Contraction in Response to ACh and PBS. Sequential images 
show a C2C12 myotube at precontraction (A), after 1µM ACh perfusion (B), PBS wash (C), and 
1mM ACh (D). The myotube perimeter was carefully and completely traced, and filled in with a solid 
color. The colors could be extracted and imported into ImageJ to make measurements of the 
myotube size in microns squared and measure changes from the original precontraction area (E).  
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Strained-activated fibroblasts regulate in vitro myotube contraction independent of 
fibroblast-regulated myotube hypertrophy 
We have developed a universally available system for examining in vitro myotube 
contraction. All myotubes from coculture experiments were found to be contractile and followed a 
sigmoidal-shaped dose response curve when perfused with increasing concentrations of ACh [10-
11-10-3 M] and a maximal stimulatory dose of KCl [10-2 M].  ACh-induced fractional shortening 
decreased myotube area by 20-30% across treatments (Figure 14B). All cocultured myotubes 
shortened 9.0-10.7% more than uniculture myotubes (P<0.05).  ED50 values for myotubes grown 
in coculture averaged 1-6nM ACh. Of the coculture groups, CSDS-treated fibroblasts decreased 
the ACh concentration needed to reach ED50 by 15.1-fold compared to the uniculture, 
respectively. The Hill slope coefficient, another index of ACh ligand binding and contractile 
potency, produced a similar result. Hill slope goodness of fit ranged from, R2 0.74-0.87. The 
average number of myotubes analyzed per HPF ranged from 5.3-7.6 per treatment (Figure 15B, 
P > 0.05) indicating that the densities of myotubes were similar across treatments and were not 
factors driving ACh sensitivity changes. 
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Treatment Maximum Shortening [ACh] ED50 Log 
[ACh] 
Slope 
Coefficient 
R2 
αBGT [5µg/ml] 95.3 ± 4.8% N/A -0.296 ± N/A N/A 
Uniculture 81.5 ± 3.3% γ -7.81 ± 0.96 -0.234 ± 0.02 0.61 
Non-strain 71.4 ± 3.0% γ * -8.35 ± 0.64 -0.306 ± 0.02 0.87 
ALDS 71.8 ± 2.7% γ * -8.27 ± 0.56 -0.298 ± 0.02 0.74 
CSDS 72.5 ± 3.7% γ * -8.98 ± 0.60 -0.427 ± 0.04* 0.82 
CSDS+ALDS 70.8 ± 5.4% γ * -8.54 ± 0.49 -0.355 ± 0.02 0.74 
  
    
Figure 14. ACh is a Necessary Component for Fibroblasts-Mediated Myotube Contraction.  
A. Fractional shortening of myotubes grown in the presence of non-strained fibroblasts in response 
to ACh [1-11-1-3M] and KCl [1-2M] normalized to a percentage of their original resting area. B. Table 
of values for in vitro myotube contraction; γ>αBGT *>uniculture, P < 0.05. 
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In the process of calculating myotube contraction the precise tracings of myotube outlines 
generated extensive data about their size. Thus we extrapolated how coculture myotubes 
responded to the fibroblasts in the context of hypertrophic growth. Myotube surface areas ranged 
from 1100-47000µm2. The average myotube size per treatment was 3500-5300µm2 (Figure 15). 
Coculture increased average myotube size by 32.5% vs. uniculture (P < 0.05), and of the 
cocultures subjected to strain, CSDS-fibroblasts increased myotube size an additional 20.2% (P = 
0.05). When ALDS was applied after CSDS myotube area decreased by 9.6% compared vs. 
CSDS only; and when applied singularly, ALDS-fibroblasts decreased myotube area by 6.2% vs. 
non-strain (P > 0.05).  
To determine whether myotube contraction was a function of size, myotubes from non-
strain coculture were bracketed into sizes: <2500, 2500-5000, 5000-7500, 7500-10000, and 
>10,000µm2, and sigmoidal dose-response curves were analyzed. We found that Hill slope 
coefficients were greatest for small myotubes <5000µm2. However, there were no significant 
differences in ED50’s among myotube sizes (0.5nM-10nM; Figure 32, Appendix). Thus we 
concluded that fibroblast-induced myotube hypertrophy did not account for the potent and specific 
contractile responses induced by ACh among coculture treatments.  
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Treatment   Myotube Size (µm2) Total Myotube Area (µm2)   Myotubes/HPF 
Uniculture 3497±122.9 18491±2398 9.64±1.9 
Non-strain 4388±283.1 26668±3488* 10.0±1.4 
ALDS 4114±222.7 30967±3500* 11.8±1.4 
CSDS 5274±334.0*λ 27870±3558* 12.5±1.8 
CSDS+ALDS 4765±286.4* 29880±3514* 11.6±1.7 
  
 
Figure 15. Fibroblast Regulate Myotube Hypertrophy. A. Distribution of all myotubes from 
uniculture and coculture treatments. B. Table of values for myotube sizes; 103-140 myotubes 
measured, N=12; *>uniculture, λ>ALDS, P<0.05. 
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ACh-Receptor binding is required for in vitro myotube contraction 
To show ACh-AChR binding is a necessary component for the progressive decreases in 
myotube area measured by our in vitro contraction apparatus, unconjugated αBGT was added to 
coculture to block myotube nAChRs. We found unconjugated αBGT [5µg/ml] incubated in 
coculture for 1 hour was sufficient to block the binding of rhodamine-conjugated αBGT with no 
detectable cytotoxic affects (Figure 31, Appendix). αBGT-treated myotubes were then perfused 
with ACh [10-11-10-3 M]. No concentration of ACh could decrease fractional shortening greater 
than 95% of the myotube’s original resting length (Figure 14A). To show αBGT-treated myotubes 
were contractile independent of nAChRs a final dose of KCl [10-2 M] was administered which 
induced significant fractional shortening from resting length, P < 0.05.   
Our PBS-based perfusate (Sigma, P3813) did not contain calcium and many adhesion 
molecules are calcium dependent. To test whether calcium-dependent adhesion affected 
fractional shortening, 1.8 mM Ca2+ was added to perfusate and ACh [10-11-10-3 M] was 
administered to myotubes differentiated in the presence of non-strained fibroblasts. Calcium-
containing perfusate had no affect on ED50 [ACh]Log versus calcium-free perfusate (-7.42 ± 0.5 
and -7.45 ± 1.1, respectively). However, calcium could not reproduce the maximum fractional 
shortening of calcium-free perfusate, by 78.5 ± 4.3% and 68.7 ± 3.8, respectively P < 0.05 (Figure 
30, Appendix). 
Together these data show that our in vitro contraction model induces a 30% decrease in 
original resting length of myotube area that is within the range of sarcomere-dependent 
shortening. Of the parameters tested, calcium-dependent adhesion molecules blocked 10% of 
fractional shortening suggesting adhesion molecules present in myotube cultures may attest for 
the isometric-like contractions identified in Figure 12. However, nAChR-inhibiton prevented all 
contractions and suggests that a major and significant source of fractional shortening is derived 
from an ACh-nAChR mediated process.  
Cyclically strained fibroblasts enhance myotube nAChR expression  
66 
As ACh-induced contractions are dependent upon ligand binding to its receptor, 
expression of nAChRs from cocultured myotubes was measured (Figure 16). Non-strain and 
ALDS-fibroblasts did not significantly alter protein expression vs. uniculture (1.50±0.37 and 
1.57±0.51 fold, respectively). However, CSDS-fibroblasts increased AChR expression vs. 
uniculture (2.36±0.43 fold, P < 0.05) and CSDS+ALDS followed a similar trend (2.46±0.79 fold, P 
= 0.10). Expression among coculture groups was not significantly different. We also measured 
nAChR expression from agrin-treated and untreated myotubes grown in differentiation media. 
Both groups expressed nAChR but were not significantly different from one another (Figure 33, 
Appendix). 
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Figure 16. NAChR Expression Measured by Western Blot 96 Hours Post-Strain. A. 
Representative band densities of nAChR (57kDa) and GAPDH (32kDa) from uniculture and 
coculture groups. B. All data expressed as fold change from uniculture, N=7; *>uniculture, 
P<0.05. 
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Cyclic strained fibroblasts disrupt AChR macroclusters formation on myotubes  
Agrin induces nAChR clustering (Grow and Gordon 2000). Therefore, agrin-treated 
myotubes were used to demonstrate that AChR macroclusters could be appropriately produced 
with our model. Figure 17 shows that agrin-treated myotubes increased αBGT-stained area (µm2) 
of macroclusters per myotube by 5-fold vs. untreated myotubes (1900±200 vs. 300±100, P < 
0.05). Using the same analysis criteria, macroclusters were measured in all coculture groups. 
Non-strained fibroblasts increased AChR macroclusters vs. uniculture by 2-fold (928±175 vs. 
438±141, P < 0.05). ALDS-fibroblasts further increased macroclusters by 3-fold (1478±190). 
Opposingly, CSDS and CSDS+ALDS-fibroblasts reduced αBGT-stained macrocluster area by 
300µm2 and 350 µm2 per myotube vs. non-strain, respectively. nAChR macrocluster areas were 
further reduced when compared with ALDS-fibroblasts, P < 0.05; and  were not statistically 
different than uniculture myotubes, P = 0.3. 
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Figure 17. CellProfiler Identified NAChR Macroclusters. A. Pixel intensity scale showing 
αBGT-stained macroclusters, ≥65%. B. Photomicrograph of total myotube nAChR fluorescent 
labeling with αBGT, 20X. Yellow arrows highlight macroclusters. C. CellProfiler overlay of 
identified macroclusters in yellow. D. Graphical representation of nAChR macroclusters. Inset 
shows effects of agrin on macroclusters in differentiation medium; *>uniculture, π>CSDS, 
T>CSDS+ALDS, δ> -Agrin; P<0.05. 
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To further characterize the unique AChR clustering patterns produced by strain-activated 
fibroblasts a histogram was created to quantify the distribution of AChR cluster size and number 
on each myotube. A total of 1966 macroclusters from 12 myotubes were identified and analyzed. 
Histogram analyses confirmed that fibroblasts increased myotube αBGT-stained macrocluster 
area both as a function of increased number as well as size (Figure 18B).  ALDS-fibroblasts 
increased macrocluster number vs. uniculture at sizes 4-8µm2, and all sizes ≥32µm2. The median 
macrocluster size was also greater than non-strained fibroblasts (P < 0.05). Non-strained 
fibroblast followed a similar trend at 4-8µm2 and 32-64µm2, but failed to reach significance at 
larger sizes vs. uniculture. CSDS and CSDS+ALDS-treated fibroblasts did not reach significance 
vs. uniculture. At cluster sizes >512µm2 CSDS and CSDS+ALDS-treated fibroblasts decreased 
myotube cluster numbers from other non-cyclically strained cocultures groups, P < 0.05. Our 
positive control, agrin-treated myotubes, increased AChR clustering by 4-10 fold across all size 
ranges vs. untreated myotubes thus validating our staining and identification techniques (Figure 
18A).  
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Treatment Macrocluster Size (µm2) Macrolusters / Myotube 
+ Agrin 20.7 ± 4.57 10.2 ± 0.89 δ 
- Agrin 20.0 ± 10.6 2.47 ± 0.82 
Uniculture 49.3 ± 19.0 2.06 ± 0.49 
Non-strain 36.0 ± 12.9 3.78 ± 0.48* 
ALDS 100 ± 23.6*,η,Τ 4.53 ± 0.36*,π,Τ 
CSDS 71.1 ± 16.4 2.68 ± 0.33 
CSDS+ALDS 51.1 ± 12.9 2.83 ± 0.47 
 
 
Figure 18. NAChR Macrocluster Distribution. Macrocluster frequency per myotube below a 
value of 1.0 indicates that for every 100 myotubes measured less than 100 had a macrocluster of 
that particular size (µm2), Log2.  A. Macroclusters from agrin-treated and untreated myotubes 
grown in differentiation media. B.  Macroclusters from myotubes grown in uniculture and 
coculture. C. Table shows the average macrocluster size, and the average number of 
macroclusters per myotube for each treatment; *>uniculture, η> non-strain, π>CSDS, 
T>CSDS+ALDS, α> +Agrin, δ> -Agrin; P < 0.05. 
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Cyclic strain-activated fibroblasts increase myotube nAChR microclusters 
Clustering data were not consistent with expression data suggesting secondary events 
caused preexisting receptors to reorganize in macroclusters. While investigating colocalization of 
nAChR clusters and myonuclei, Englander and colleagues found an inverse distribution between 
macroclusters and nAChR microaggregates (Englander and Rubin 1987). We predicted the 
fluorescent intensity of microaggregates may fall below the ≥65% threshold defined by agrin-
induced clustering accounting for the inconsistency between our clustering and expression data. 
To show a proof of concept that strain-activated fibroblast were capable of reorganizing nAChRs 
in this context, microclusters and macro:microcluster ratios were quantified. 
AChR microclusters were defined as the αBGT-stained area occupied on myotubes 
<65% intensity (Figure 19A). Microcluster regions occupied 12-fold more area per myotube than 
macrocluster regions for cocultures, and occupied 13.4-fold more area for uniculture (P < 0.05).  
CSDS and CSDS+ALDS-fibroblasts increased the per myotube coverage of AChR 
microclustering vs. uniculture by 3300µm2 and 4800µm2, respectively (Figure 19D, P < 0.05). 
While microcluster coverage per myotube also increased for non-strain and ALDS-fibroblasts by 
2600µm2 and 2000µm2  vs. uniculture, respectively; these data were not significant (P = 0.06 and 
P = 0.16).  The positive control, agrin-treated myotubes, had no effect on AChR microclustering 
vs. untreated myotubes (7900±25 vs. 9100±1000), suggesting that microclusters are not 
regulated by an agrin-dependent pathway.   
Agrin-treated myotubes contained 17% of their αBGT-stained area in macroclusters while 
untreated myotubes contained only 3%, P < 0.05. Of the treatment groups, uniculture and 
nonstrain coculture macroclusters occupied 7.6% and 9.1%, respectively. ALDS macrocluster 
regions occupied 14% of the myotube region, which was significantly greater than CSDS and 
CSDS+ALDS occupied regions 5.6 and 5.3%, respectively; P < 0.05 (Figure 34, Appendix).   
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Figure 19. CellProfiler Identified nAChR Microclusters. A. Pixel intensity scale showing 
αBGT-stained microclusters, <65%. B. Photomicrograph of myotube nAChR fluorescent labeling 
with αBGT, 20X. Orange arrows highlight microclusters. C. CellProfiler overlay of identified 
microclusters in orange. D. Graphical representation of nAChR microclusters. Inset shows effects 
of agrin on microclusters in differentiation medium; *>uniculture, δ> -Agrin, p<0.05. 
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Myotube contractile sensitivity correlates with increased AChR expression and 
microclustering 
The ED50 values for each coculture treatment were plotted against AChR expression, 
AChR macroclusters and AChR microclusters, and linear regression analyses calculated (Figure 
20A-C).  ED50 and AChR expression correlated in a manner that suggests increased AChR 
expression results in increased myotube contractile sensitivity towards ACh, R2=0.88. ED50 
values also correlated with AChR microclustering, R2=0.85, but did not correlate with AChR 
macroclustering, R2=0.13. AChR expression and microclustering, but not macroclustering, were 
also correlated. There was no correlation between macroclustering and microclustering (Figure 
20D-F). 
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Figure 20. Linear regression analyses among coculture and uniculture contraction, nAChR 
expression and clustering. A.  AChR expression and contraction. B. Macrocluster and 
contraction. C. Microcluster and contraction. D. Macroclusters and expression. E. Microclusters 
and expression. F. Macroclusters and microclusters. 
A.  
C.  
E.  
B.  
D.  
F.  
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Discussion 
Muscle damage occurs in response to injury, inflammation, and chronic disease. Utilizing 
cellular strategies that target endogenous cells within the body to improve muscle repair and 
function is timely as we are now entering an era where it is possible to evaluate the integrated 
effects of several cell types (Bentzinger, Wang et al. 2013). We have previously shown that 
fibroblasts, which exist in tissues juxtaposed to skeletal muscle, are activated through mechanical 
strain to secrete cytokines, such as Interleukin-6, to enhance myoblast differentiation (Hicks, Cao 
et al. 2012). We confirmed that fibroblasts, and not fluid forces, are inducing myoblast 
differentiation without affecting cytoxicity over the 96 hour duration without media change. This 
study shows fibroblasts also profoundly affect the functional phenotype of myotubes differentiated 
in their presence, and when activated by mechanical strain, fibroblasts further modify nAChR 
expression and clustering.  
Our data show myotubes respond to acetylcholine (ACh) by shortening in length and 
area. Low doses of ACh induce myotubes to shorten and return to original resting position after 
PBS wash supporting evidence for in vitro contraction. While reversible contractions could be 
measured using the coordinates of intracellular myonuclei for distance comparisons, we decided 
against using these measurements because the magnitude of contraction varied significantly 
depending on the coordinate in the myotube selected. In response to larger doses of ACh, 
myotubes reached a threshold in which contraction resulted in loss of cell adhesion which did not 
return to original resting length following PBS wash. Importantly, we show that increased doses of 
ACh and KCl result in cumulative loss of cell adhesion consistently measurable across all 
treatment groups.  
Our in vitro contraction model highlights the fact that fibroblasts promote the 
differentiation of highly contractile myotubes. In no instance did strained or non-strained 
fibroblasts desensitize ACh-induced myotube contraction. However, our experimentally-derived 
hill coefficients for ACh-induced myotube shortening are less cooperative than pharmalogical-
derived ACh-AChRs binding hill coefficients, found in the ranges of 0.2-0.4 and 1.2-1.6, 
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respectively (Witzemann 2006). Figure 12 gives one possible explanation showing that low doses 
of ACh induce isometric-like contractions in which intracellular structures shorten but no change 
in total myotube length or area are measured. We speculate that the reduced hill coefficients may 
in part be due to cell attachments that delay the progressive decrease in myotube area used to 
create the dose response curves. Cell attachments in the form of ECM proteins could be derived 
from the myotubes or soluble proteins secreted by the fibroblasts that find their way to the 
myotubes. It is also possible fibroblasts secrete proteases, such as MMPs, that weaken myotube 
attachments and thus increase hill coefficients, such as in the case of CSDS-treatment. The 
density of myotubes used to compile contraction videos was similar among all groups (Figure 
15B) providing evidence against the possibility that myotube density was affecting nearby 
contraction. Of the parameters tested, AChRs were found necessary for contraction (Figure 14A), 
but not sufficient to reproduce ACh-AChR hill coefficients. Cofactors regulating the AChR 
complex, such as MuSK, may also regulate in vitro myotube contraction; however it was beyond 
the scope of this study to determine which other cofactors potentially affected our in vitro 
contraction model as several candidates are reasonably possible.  
Our results on fibroblast-stimulated myotube contraction complement the research of 
Cooper et al. showing C2C12 myotubes grown on a fibroblast-feeder layer prolonged viability and 
produced functionally mature myofilaments (Cooper, Maxwell et al. 2004). Cooper et al. partially 
attributed the myotube’s functional maturity to the secretion of ECM components and growth 
factors derived from the fibroblasts. We support the idea that fibroblasts secrete mediators that 
affect myotube contraction as cells in our coculture were spatially separated and could only 
interact through paracrine mechanisms. We also showed that strain-activated fibroblasts regulate 
myotube contractile sensitivity and support nAChR regulation as a potential mechanism. 
We found that cyclically strained fibroblasts increase myotube nAChR expression which 
correlated to ED50 sensitivity changes (Figure 20A). The increased expression of nAChR may be 
in response to the unique fibroblast cytokine secretion profile activated by CSDS. Our laboratory 
has previously quantified the secretion of sixty CSDS-derived cytokines that include many 
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candidates of nAChR expression and motoneuron plasticity  (Meltzer and Standley 2007). For 
example, CSDS-fibroblasts upregulate TNFα and IFNλ that, in turn, upregulate nAChR 
expression (Poea-Guyon, Christadoss et al. 2005). Thus we speculate strain-activated fibroblasts 
could secrete cytokines that direct neuromuscular communication. 
Skeletal muscle nAChRs are continuously internalized and degraded, or transcribed and 
integrated into the sarcolemma. We show that agrin induces myotube macroclustering by >2 fold 
compared to all other treatments, and the presence of fibroblasts also aggregated nAChRs into 
macroclusters (Figure 18). While fibroblasts do not appear to express agrin (Yang, Cao et al. 
2001), there are several potent and specific mediators for nAChR clustering that fibroblasts 
secrete, such as neuregulin-1, which are implicated in the regulation of synapse formation and 
maintenance (Choi, Wolber et al. 2010; Ngo, Cole et al. 2012). ALDS-fibroblasts further induced 
the formation of macroclusters suggesting an additive effect of one or more secreted mediators, 
or a repression of one or more proteolytic enzymes targeting the disruption of macrocluster 
formation, such as through the actions of a secreted protease inhibitor (Zhu, Xiong et al. 2006). 
Identifying how ALDS-fibroblasts regulate nAChR clustering is an area of future interest. 
Cyclically-strained fibroblasts decreased nAChR macrocluster formation. This 
contradicted our initial hypothesis that nAChR expression and clustering would be proportional 
based on the assumption that more receptors should result in more intense fluorescent staining of 
random clusters. Supporting the idea that nAChR expression and macroclustering are 
independently controlled events, agrin-treated myotubes increased macrocluster aggregation by 
>5-fold, but had no effect on protein expression. We also found that untreated myotubes were 6.5 
times more likely to contain nAChRs in microclustered regions suggesting that agrin works by 
remodeling preexisting receptors into macroclusters but does not induce the expression of 
additional receptors. These data are supported by Englander et al. whose research found 
nAChRs preferentially exist in microaggregates, but when treated with an extract from Torpedo 
electric tissue nAChRs coalesce in larger clusters. Englander and colleagues showed an inverse 
distribution between microaggegates and larger clusters which they suggested were mobile 
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(Englander and Rubin et al. 1987). In our hands, myotubes differentiated in the presence of 
strained fibroblasts also formed macroclusters inversely correlated with microcluster stained 
regions. Figure 20D shows that coculture treatments with the greatest macroclustering had the 
least microclusters, and vice versa. In our coculture, the formation of low-pixel intensity nAChR 
microclusters also closely followed protein expression (Figure 20C) suggesting that nAChRs are 
initially introduced into the muscle sarcolemma as microclusters and separate regulatory 
mechanisms control their aggregation to macroclusters.  
Taking into account that non-strained fibroblasts induce macroclusters, while CSDS-
fibroblasts decrease macroclusters and increase expression, we speculate the following as one 
possibility. CSDS-fibroblasts are demonstrated to be phenotypically similar to fibroblasts derived 
from injury (Meltzer, Cao et al. 2010) and secretion of both lysosomal and non-lysosomal 
proteases are up-regulated by fibroblasts during injury and prolonged periods of biomechanical 
strain (Belcastro, Shewchuk et al. 1998). We speculate that CSDS-fibroblasts mediate proteolytic 
disruption of AChR macroclusters followed by compensatory upregulation of AChR expression as 
suggested by Guyon et al. who demonstrated this common phenomenon in experimental 
autoimmune myasthenia gravis (EAMG) (Guyon, Wakkach et al. 1998). EAMG inoculates 
otherwise healthy animals with antibodies against nAChR which disrupts macrocluster formation 
and subsequently nAChR expression increases (Guyon, Wakkach et al. 1998). EAMG is 
associated with increased TNFα and IFNλ that CSDS-fibroblasts also secrete. 
The hypothesis that nAChR macrocluster aggregation would correlate to increased 
contractile sensitivity, perhaps through synchronous depolarization, turned out to be incorrect. In 
fact, the opposite was found to be true. ED50 values correlated with nAChR microclustering. One 
potential source for consistency in the literature is in the field of muscle denervation. In 
denervated muscle, nAChR clusters dispurse across the sarcolemma and protein expression 
increases (Cohen, Waddell et al. 2007). Bernareggi et al. also found that microtransplantation of 
nAChRs derived from denervated muscle generate ACh currents that are 50 times stronger than 
those elicited from innervated muscle (Bernareggi, Reyes-Ruiz et al. 2011). Similarly, our CSDS 
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regimen modeling repetitive stress/injury hypersensitized myotubes to ACh (Figure 14), increased 
nAChR expression and dispersed clusters. We offer that fascia fibroblasts may be one potential 
source regulating the myofiber phenotype during repetitive movements. Of clinical significance, 
focal dystonias are a common risk factor of repetitive strain injuries that are treated with Botox to 
inhibit acetylcholine release and stop hypersensitive muscle contraction (Rogozhin, Pang et al. 
2008). While our coculture does not contain motoneurons, it is tempting to speculate the roles for 
strain and fibroblasts in these clinical settings, and we support the future use of animal and 
human models to validate our findings, such as through the use innovative techniques (Chung, 
Wallace et al. 2013) to track nAChR clustering in repetitively strained tissues that could lead to 
novel therapeutics targeting fibroblasts. 
We have previously shown that 1 minute of ALDS can reverse CSDS-induced 
disorganization of fibroblast actin architecture, and proximally decreases lamellipodia as to 
change fibroblast morphology from an elongated to a stellate shape (Meltzer, Cao et al. 2010). 
Similar manual therapy techniques that apply long-duration strain to fibroblast-rich tissues are 
clinically prescribed to correct somatic dysfunction associated with musculoskeletal injuries 
(Licciardone, Minotti et al. 2013) in order to restore muscle function (Kokkonen, Nelson et al. 
2007; Dalbello-Haas, Florence et al. 2008). Therefore, we were keenly interested in applying a 
modeled manipulative treatment to fibroblasts and measuring functional outcomes in myotubes. 
We show that ALDS-fibroblasts increased nAChR macrocluster number and size on myotubes 
(Figure 18B). Maintenance of the neuromuscular junction is critical for preventing axonopathies 
associated with motoneuron diseases such as amyotrophic lateral sclerosis and spinal muscular 
atrophy (Ferri, Sanes et al. 2003), and evidence supporting cellular strategies that provide nAChR 
cluster stability should be explored in greater detail. We do not want to overreach on any 
interpretation for the significance of ALDS-treated fibroblasts in our in vitro setting; however, it is 
conceivable that just as Schwann cells and motoneurons regulate NMJs through paracrine 
processes (Feng and Ko 2008), fibroblasts which are highly adaptable to biomechanical strain 
and juxtaposed to nAChRs during strain-induced muscle contraction, might also contribute to this 
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process. Therefore methods to improve nAChR clustering and expression, i.e. through 
engraftment of bioengineered skeletal muscle seeded with strain-activated fibroblasts, or through 
physical therapy regimens targeting fibroblast-rich tissue, may help neuromuscular innervation, 
and improve clinical outcomes associated with neuromuscular disorders. 
While many experimental approaches are currently being developed to address the 
effects of multiple cell types on muscle regeneration (Joe, Yi et al. 2010; Briggs and Morgan 
2013), our simple coculture system modeled after a myofascial junction shows proof of concept 
that fibroblasts are a novel cell type directing all stages of myoblast differentiation including 
myotube contractility and nAChR rearrangement. Our coculture has the potential to be expanded 
to investigate interactions between multiple cell types, including fibroblast-regulated innervation of 
skeletal muscles to motoneurons, and strain-activated fibroblast-induced class switching of other 
cells involved in muscle regeneration, such as M1 and M2 macrophages (Tidball and Villalta 
2010). We speculate biomechanical strain serves as one stimulus regulating phenotypic shifts in 
fibroblasts to promote or inhibit muscle regeneration and provide evidence that cyclic and acyclic-
strained fibroblasts have profoundly different effects on nearby muscle cells. However, we 
examined only three strain paradigms, and have recently shown that variations to our ALDS 
model in strain magnitude and duration elicit many different fibroblast responses (Cao, Hicks et 
al. 2013). We support the future use and optimization of strain paradigms to investigate additional 
fibroblast responses that could lead to novel strategies to improve skeletal muscle regeneration. 
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CHAPTER 4: CONCLUSIONS 
 
This study was set out to explore the interaction between skeletal muscle and fibroblasts, 
and has identified fibroblasts as important regulators of myoblast differentiation and myotube 
function. The study constructed a novel coculture that allows one cell type to be independently 
subjected to mechanical strain regimens while simultaneously interacting with an adjacent cell 
type through paracrine mechanisms. Strain-induced fluid forces had negligible effects on the 
adjacent cell in the context of proliferation and differentiation, thus the coculture may have 
applications for many biomedical research studies. Ours modeled the myofascial junction as it 
exists in vivo. A major finding of this work was that the application of mechanical strain to 
fibroblasts can significantly change the phenotype of nearby skeletal muscle cells. Therefore this 
work provides proof-of-principle that strain manipulation of fibroblasts varying in duration, 
frequency, and magnitude can serve as a vehicle to direct fibroblast-mediated effects on skeletal 
myoblast differentiation and myotube functionality. The study developed an algorithm-based 
software package to identify acetylcholine receptor (AChR) clustering that is now being used by 
other labs (Ball, Campbell et al. 2013) and a perfusion system to show ligand-mediated muscle 
contraction per individual cell in vitro. The study found cyclic short-duration strain (CSDS) 
increased AChR expression which sensitized muscles to contract, and acyclic long-duration strain 
(ALDS), while not changing AChR expression, profoundly increased AChR cluster size. The 
coculture was also used as a platform to study paracrine signaling and identified the strain-
regulated cytokine Interleukin-6 as a necessary, but not sufficient, messenger for fibroblast-
mediated myoblast differentiation.  
Emerging literature from the scientific community supports the idea that fibroblasts are an 
important cellular component for muscle regeneration. This study’s beginnings helped pioneer 
evidence in support for this role. We began in 2007 by showing that dermal fibroblasts promoted 
cardiomyocyte proliferation and angiogenesis after infarct in the rat myocardium. We also found 
that these fibroblasts were a rich source of cytokines including HGF, VEGF, bFGF, IL-6, PDGF-β, 
and angiogenin which were influenced by mechanical strain (Hicks, Meltzer, et al. 2008). To my 
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knowledge only two studies were published on fibroblasts and skeletal muscle at that time. One 
showed conditioned media from non-myogenic, fibroblast-like cells prolonged the proliferative 
phase of double-muscling cattle myoblasts (Quinn, Ong et al. 1990). The other study dealt with 
myotubes grown on a fibroblast-feeder layer that resulted in increased myotube fusion efficiency 
and development of sarcomeres (Cooper, Maxwell et al. 2004). The current study used a series 
conditioned media crossover experiments to compliment unanswered questions about the 
mechanisms by which fibroblasts could influence repair and maturity of skeletal muscle by 
confirming that fibroblasts induce the differentiation of both mouse and human skeletal myoblasts 
(Figure 6 and Figure 34, Hicks et al. JAOA 2009), and expanded on previous work by 
experimentally determining IL-6 is a necessary messenger for fibroblast-mediated differentiation 
(Figures 8-10 and 23; Hicks, Cao et al. FASEB 2011). All other reports before 2010 dealing with 
the topic fibroblasts and skeletal muscle were given from the perspective that fibroblast-produced 
collagen increased fibrosis and impaired muscle regeneration during instances of tissue damage 
and in chronic diseases such as muscular dystrophy (Morgan, Gross et al. 2002; Serrano and 
Munoz-Canoves 2010). 
Contrasting evidence for the role of fibroblasts in muscle repair as being producers of 
fibrosis and inflammation, or promoters of myoblast proliferation and myotube fusion supports the 
idea that fibroblasts serve dual roles in muscle repair. In vivo, these actions could likely contribute 
to the biphasic process of muscle regeneration by recruiting leukocytes that remove necrotic 
tissues and activating myoblasts during the inflammatory phase (Buckley, Pilling et al. 2001), or 
contributing to  the resolution of muscle damage by withdrawing survival signals, normalizing 
chemokine gradients that cause profibrotic cells to undergo apoptosis and/or quiescence, and 
cause infiltrating cells to emigrate from the muscle during the regenerative phase (Flavell, Hou et 
al. 2008). This study concludes that fibroblasts secrete proinflammatory cytokines when 
subjected to strain models of stress/injury, but secrete anti-inflammatory cytokines when 
subjected to strain models of manipulative treatments. Thus mechanical strain can serve as a 
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vehicle to induce phenotypic shifting in fibroblasts, and may serve as a useful model to further 
characterize such biphasic, and conflicting, responses in the fibroblast.    
Similar phenotypic shifts are documented in tissue macrophages during muscle 
regeneration. M1 phagocytic populations switch to an M2 population that promotes muscle 
growth, differentiation, and regeneration. Experiments by Dr. James Tidball’s laboratory used 
cytokines IL-4, IFNγ, and IL-10 and enzymatic competition tailored to the unique protein 
expression profiles of M1 and M2-macrophages to induce an M2-class macrophage shift (Villalta, 
Bakkar et al. 2009). In skeletal muscle, the molecular switch regulating the mutually exclusive 
decisions of differentiation and self-renewal in muscle satellite cells has also recently been 
addressed. Data from Dr. Jeanne Wilson-Rawls’ laboratory showed that genetic ablation of 
Numb, an inhibitor of the notch ligand, can prevent satellite cell activation by derepression of the 
myostatin pathway (George, Biressi et al. 2013). Thus phenotypic switches occur in many 
instances and cell types in muscle repair, and therapeutic interventions that affect the balance of 
activation among cellular populations may influence the course of muscle regeneration including 
for skeletal muscle diseases. Evidence from this study provides proof of concept that being able 
to produce fibroblasts of different phenotypic statuses e.g. via biomechanics, and at different time 
points, may be optimal for inducing muscle hyperplasia, hypertrophy, and improving functionality.  
Myofascial release and other versions of manipulative treatment have documented roles 
in resolving muscle inflammation and reducing delayed onset muscle soreness after acute 
muscle injury (Hilbert, Sforzo et al. 2003). In support of manipulative treatment outcomes, this 
study shows ALDS treatment applied after a CSDS stress/injury augments fibroblast-mediated 
myoblast differentiation (Figure 7). The data also show ALDS-fibroblasts could not enhance 
differentiation of myoblasts that had not first been exposed to CSDS-fibroblasts. Corroborating 
with the idea that myoblast activation must first occur prior to a speculated manipulative 
treatment-induced regenerative milieu, many studies have shown that prophylactic inflammatory 
suppression, such as by athletes using non-steroid anti-inflammatory drugs as a prophylactic 
medication for muscle strain injury, reduces myoblast activation and impairs the efficiency of 
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regeneration (Mackey, Mekkelsen et al. 2012). The importance of the manipulative treatment may 
be that sustained inflammation is catastrophic to muscle regeneration and results in the canonical 
model of fibroblast-derived fibrotic deposition (Serrano, Munos-Canoves, 2010). It is tempting to 
speculate that manipulative treatments targeting fibroblast-rich tissue can induce a phenotypic 
shift, after CSDS-induced cytokines first activate myoblasts that induces anti-inflammatory 
cytokines and a regenerative-favoring milieu. To test whether the CSDS paradigm could induce 
fibroblast-mediated myoblast activation early gene expression of myogenin and MyoD were 
measured. CSDS increased myogenin expression by 13-fold vs. uniculture, while non-strain 
increased myogenin by only 8-fold vs. uniculture (P < 0.05, Figure 27) suggesting a trend towards 
both greater and earlier activation by CSDS. Our preliminary data also showed ALDS-fibroblasts 
reduced myoblast expression of myogenin. Our data suggest a strong proinflammatory 
environment by the application of the CSDS paradigm. Taken together, these data suggest that 
transient activation of fibroblasts followed by suppression of inflammatory cytokines is essential 
for optimizing myoblast differentiation.   
This study provides empirical evidence for a role of strain-induced phenotypic switching 
of fibroblasts that resembles a biphasic-like response of muscle regeneration. If I were to test this 
concept directly, I would design a genetic manipulation experiment to transiently regulate the 
inflammatory pathways fibroblasts. One could integrate a cre-lox system into fibroblasts that turns 
on and off NFKβ, or other signaling pathways with the goal of measuring myoblast activation and 
differentiation in coculture. One could similarly use the cre-lox system during strain regimens and 
determine whether strained-fibroblasts could still modify myoblasts. One could also measure 
proteomic expression of these genetically-modified fibroblasts and determine whether they 
resembled the proteomic expression of fibroblasts after mechanical activation. During the tenure 
of this study, I assisted in a project that measured the expression and activation of 800 fibroblast 
proteins in response to these biomechanical strain regimens (Cao, Hicks et al. 2012).  
Significant progress has been made in the past three years identifying the role of 
fibroblasts in muscle repair. In 2011, Dr. Gabrielle Kardon’s laboratory confirmed fibroblasts are 
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closely associated with the developing muscle by identifying a novel transcription factor (Tcf4) as 
an excellent marker of muscle connective tissue fibroblasts (Mathew, Hansen et al. 2011). 
Kardon et al. then demonstrated that fibroblasts are a vital component of the niche regulating 
satellite cell expansion by using Tcf4Cre mice to ablate muscle fibroblasts. Genetic ablation 
resulted in the depletion of satellite cells and reduced the maturation of myofibers after injury 
(Murphy, Lawson et al. 2011).  
Despite Kardon’s findings, and the abundance of fibroblasts in connective tissues, 
fibroblasts remain poorly characterized in molecular terms. Currently, fibroblasts are most often 
identified by their lack of lineage markers for other cell types, and as a major step in the 
development of treatments for fibrotic diseases identifying a reliable and specific fibroblast marker 
is needed. In skeletal muscle, markers such as CD45 (hematopoietic), CD31 (endothelial), and 
α7-Integrin (muscle satellite cell) can be used to remove non-fibroblast cells by negative lineage 
sorting leaving behind non-lineage populations of heterogeneous fibroblastic cells yet to be 
characterized. Seminal reports in Nature Cell Biology and Nature Medicine have recently 
identified two of these populations with unique biphasic roles in the regeneration process. The 
CD31-CD45-Sca1+CD34+ fibroblasts transiently promote muscle regeneration or can differentiate 
into fibrotic and adipogenic cells (Joe, Yi et al. 2010); and the CD31-CD45-PDGFR+ADAM12+ 
fibroblasts can transiently promote muscle regeneration or become myofibroblasts (Dulauroy, 
Carlo et al. 2012). Findings from Joe and Dulauroy et al. beg the question to whether there exists 
fibroblast populations that uniquely respond to biological conditions and regulate the progression 
of fibrotic diseases, such as scleroderma. 
Just as Dr. Tidball’s laboratory designed specific strategies to help M2-macrophages 
outcompete M1-macrophages for assisting in muscle regeneration, identifying unique fibroblast 
populations is a major step in designing clinical interventions that promote healthy, beneficial 
fibroblasts to thrive in areas of disease. I have two pending grants to further characterize 
fibroblast populations in a mouse model of muscular dystrophy and hope to identify novel 
therapeutic targets aimed at reducing fibrosis in the most fibrotic-prone subgroups. Findings from 
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that proposal hope to aid in muscle regeneration studies and improve the delivery of 
oligonucleotide exon skipping drugs (Hicks and Morgan, 2013). 
In the context of this study, it would be interesting to identify whether fibroblast 
populations of distinct topographic differentiation and positional memory behave differently given 
a mechanical stimulus. One could speculate that fascia fibroblasts from one anatomical region 
could secrete cytokines that differ from fibroblasts of another region even using the same 
myofascial release technique, and thus uniquely affect nearby tissues. Such an idea should be 
explored in greater detail to broaden evidence in support for manipulative treatments. 
 At the heart of reprogramming fibroblasts for biomedical research, may lie 
fibro/adipogenic progenitors (FAPs) that can differentiate into multiple cell types including 
fibroblasts given different stimuli.  Activated FAPs have been shown to significantly increase the 
frequency of proliferating satellite cells that commit to terminal differentiation (Joe, Yi et al. 2010) 
and many labs are now exploring the possibility for FAPs to induce muscle regeneration in 
chronic degenerative diseases (Mozzetta, Consalvi et al. 2013). As other vertebrates regenerate 
muscle more efficiently than mammals, and important cellular processes are often evolutionarily 
conserved, I was recently awarded a grant to identify FAPs in limb regeneration across vertebrate 
species (Hicks, Massimo et al. 2014).  
Carrying regeneration through to the maturation of myotubes is the ultimate goal for 
recovering functional skeletal muscle after injury. This study is the first of its kind to show direct 
evidence that mechanical stain of fibroblasts dramatically impacts the functional phenotype of 
myotubes. ALDS resulted in significantly larger nAChR clusters than non-strain fibroblasts (Figure 
18). In this case, we speculate that the anti-inflammatory milieu of ALDS may contain signals that 
allow clusters of larger size to aggregate. Such empirical evidence may have clinical significance 
for motor unit recruitment and neuromuscular diseases. An elegant study by Vivian Budnik’s 
group found that skeletal muscle receives paracrine signals from other cell types to initiate 
assembly of exosome vesicles that serve as retrograde signals inducing synaptic bouton 
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formation (Korkut, Li et al. 2012). My study shows proof of concept that fibroblasts are a potential 
cellular source for inducing phenotypic changes in skeletal muscle related to neuromuscular 
transmission (Figures 16-19); therefore it is conceivable that fibroblasts can induce a similar 
response by the muscle to assemble retrograde signals that contribute to motoneuron plasticity. 
Manipulative therapies are currently being explored as an experimental approach to alleviate 
symptoms of amyotrophic lateral sclerosis and preliminary data show therapies improve the 
functional rating scale for ALS (Dalbello-Haas, Florence et al. 2013). While these strain 
modifications are known to influence fibroblasts mechanotransduction, exploring this concept was 
beyond the scope of my current study. However, future work investigating whether fibroblasts can 
upregulate skeletal muscle exosomes that induce motoneuron plasticity could likely show 
molecular evidence that physical therapies are beneficial to neuromuscular diseases (Wilson and 
Deschenes 2005).  
Manipulative therapies that target fibroblast-rich tissue are aimed at repairing and 
inducing hypertrophy of preexisting muscles and thus this study’s exploration of fibroblast effects 
on the phenotype of differentiated myotube is clinically significant. For one reason myoblasts and 
myotubes have very different proteomics and therefore may respond to cytokine secretion in 
different manners (Kislinger, Gramolini et al. 2005). Thus strategies that selectively target 
fibroblasts to modify preexisting muscle may improve muscle function independently of whether 
myoblast activation and differentiation have occurred. Although in many clinical contexts applying 
mechanical force to the fascia would similarly apply force to the underlying muscle, superficial 
fascia may also freely slide over the muscle on viscoelastic beds of proteoglycans and hyaluronic 
acids. One of the significant findings of this study is that CSDS fibroblasts increase the 
expression of AChRs (Figure 16) and these data correlated with increased myotube contractile 
sensitivity towards acetylcholine. ALDS applied after CSDS, was not capable of further mediating 
CSDS effects of nAChR expression nor contractile sensitivity. CSDS also disrupted the ability of 
macroclusters to form and CSDS+ALDS could not rescue this disruption. While we address the 
significance of AChR cluster disruption in detail in Chapter 3, pages 92-94, we find it interesting 
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that these data are not correlated with the fibroblasts-mediated myoblast differentiation. These 
conflicting data suggest that the biological mechanisms, while coupled, are separately mediated 
events. These mechanisms could include different receptors expressed by myoblasts and 
myotubes that uniquely interact with the fibroblasts, or fibroblasts may have modified the 
phenotype of the myotubes differentiated in their presence. 
While several papers now agree that fibroblasts are important for myoblast differentiation, 
we were among the first to identify a cytokine, Interleukin-6, that significantly impacted fibroblast-
mediated differentiation. We also made an important discovery that myoblasts can increase 
fibroblast secretion of IL-6. This is important because in instances where myoblasts are ablated, 
such as in Dr. Peterson’s Pax7 knockout mice (Fry, Lee et al. 2014), fibroblasts proliferate and 
infiltrate the stem cell niche, preventing the remaining satellite cells from expansion and 
regeneration within the muscle. Just as we show fibroblasts induce responses in the myoblast, 
myoblasts reciprocally interact with the fibroblasts most likely through several mechanisms. 
Understanding more about the mechanisms by which these cells communicate, specifically 
through paracrine mediators, may be a promising area for future research such as for therapies 
aimed to ablate genetically-deficient satellite cells and engraft healthy donor satellite cells in the 
stem cell niche for muscular dystrophy therapeutics (Boldrin, Neal et al. 2012). 
Fibroblast have major and significant effects on structural integrity biomaterials. Recent 
studies demonstrated that biomimetic muscle ECM substrates substantially increased the 
expression of myogenic differentiation markers and enhanced myoblast fusion resulting in 
formation of large multinucleated myotubes, in a 3-dimensional setting (Hinds, Bian et al. 2011). 
Further skeletal satellite cells lose their regenerative capabilities when placed in an in vivo 
environment (Gilbert, Crosgrove et al. 2012). Fibroblasts, which are key to producing muscle 
ECM substrates should thus be considered in any muscle engineering proposal. The use of 
biomechanical stimulated fibroblasts may be used to manipulate cell-matrix interactions, and 
represents a potentially important target for improving structural integrity and contractile force 
generation in engineered skeletal muscle. Ongoing research in Dr. Paul Standley’s lab is 
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investigating the arrangement of collagen fibers in three dimensional bioengineered tendons. 
Perhaps adding them into 3-dimensional grafts incorporated with muscle fascia fibroblasts would 
be conducive of an in vivo environment allowing for better regeneration strategies. 
It is becoming increasingly self-evident that myofibers and satellite cells are dynamically 
regulated by other cells and tissues through the actions of paracrine cytokines, metabolites, 
exosomes, and matrix components. Secreted factors from nearby fibroblasts (including stromal 
cells, profibrotic interstitial cells, mesenchymal stem cells, fibro/adipogenic progenitors (Joe, Yi et 
al. 2010), pericytes (Dellavalle, Sampaolesi et al. 2007), angioblasts (Torrente, Belicchi et al. 
2004) macrophages and neutrophils (Tidball and Villalta 2010), endothelial cells, neurons, and 
others are essential for directing all stages of muscle regeneration. Using our coculture for future 
studies or designing 3-dimensional tissue constructs to engineer multiculture in situ-like models to 
investigate how multiple heterogeneous populations interact with fibroblast-mediated skeletal 
muscle repair will bring us one step closer to optimal regeneration strategies for improved human 
health and quality of life.  
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SUPPLEMENTAL FIGURES 
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The appendix contains a series of supplemental figures from control experiments in 
relation to the main findings of this study. Data from these experiments were discussed in the 
peer-reviewed publications derived from chapters 2 and 3, but included due to figure limits were 
included as data not shown. In the body of this work they are referenced appropriately as Figures 
21-34, and serve to support the findings, conclusions, and claims made in my dissertation. 
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Figure 21. Effects of Strain and Coculture on Fibroblasts Proliferation. Double-stranded 
DNA was measured by calometric assay at the time of myotube analyses for fibroblasts from 
coculture and strain was measured at 96 hours (A). To verify myoblasts did not crossover to 
empty Bioflex wells during strain regimens proliferation was again measured (B).  No differences 
among differentiation parameters were observed, N=6. 
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Figure 22. Effects of Strain and Coculture on Fibroblasts Morphology. Fibroblasts actin 
morphology was measured 3 hours after CSDS, at the time of the ALDS paradigm (A), and in all 
strain groups 96 hours post-strain (B). The 96 hour time point suggests that fibroblast reached 
confluence and therefore, the no change in proliferation (Figure 21) is likely a function of contact 
inhibition. 
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Figure 23: Secretion of Interleukin-6 by C2C12 Cells. The human IL-6 ELISA did not detect 
human IL-6 in C2C12 uniculture (A), N=3. The mouse IL-6 ELISA shows fibroblasts do not 
increase C2C12-derived IL-6 and CSDS and CSDS+ALDS significantly decreased IL-6 detection 
96 hours post-strain; P < 0.05, N=3. While decreases in C2C12 IL-6 could result from less 
secretion, cellular uptake, or degradation on pages 54-54 and 91-92 we suggest that CSDS-
derived degradation is likely responsible. 
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Figure 24. Effects of Exogenous Interleukin-6 in Coculture. Exogenous IL-6 doses (0-100 
ng/ml) had no effect on the number of myotubes differentiated after 96 hours, N=3. 
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Figure 25. Detection of Exogenous Interleukin-6 in Myoblast Uniculture. ELISA 
measurements were taken after addition of 0.0ng/ml, 1.0ng/ml, and 100ng/ml; between 5-0.5% of 
original exogenous IL-6 dose could be immunologically detected after 96 hours, N=3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V
eh
ic
le 1.
0
10
0.
0
0
50
100
250
500
750
Exogenous hrIL6 (ng/ml)
In
te
rl
e
u
k
in
-6
 (
p
g
/m
l)
106 
0
20
.0
20
0.
0 0
20
.0
20
0.
0
0
1
2
3
4
Neutralizing Antibody (g/ml)
Differentiation Media Growth Media
M
y
o
tu
b
e
s
 /
 H
P
F
0
20
.0
20
0.
0 0
20
.0
20
0.
0
0
2
4
6
8
10
Neutralizing Antibody (g/ml)
Differentiation Media Growth Media
N
u
c
e
i 
/ 
M
y
o
tu
b
e
0
20
.0
20
0.
0 0
20
.0
20
0.
0
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
F
u
s
io
n
 E
ff
ic
ie
n
c
y
Neutralizing Antibody (g/ml)
 
 
A.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Effects of Neutralizing Interleukin-6 in Uniculture. Horse serum was used to create 
differentiation media (grey bars) and 10% FBS was used for growth media (white bars). There was 
no effect on differentiation in response to neutralizing IL6 for respective media. These data further 
support the necessary role of fibroblasts in the requirement for C2C12 differentiation, N=3. 
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Figure 27. Fibroblast Induce Myogenin and MyoD Expression. 24 hours post-strain. These 
data show that myogenin expression increases in non-strain coculture by 8.8-fold and in CSDS 
coculture by 13.3-fold vs. uniculture, P < 0.05.  MyoD, an earlier marker of myogenic lineage 
commitment, did not increase in C2C12 cells indicating these cells are non-quiescent, activated 
myogenic progenitors. Insets show C2C12 cells grown in differentiation media (2% horse serum) 
and growth media (10% FBS) for corresponding time points. 
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Figure 28. Effects of No Media Change on Cell Death. Trypan blue exclusion was performed 
on C2C12s grown in manufacturer-recommended conditions (13.3x104 cells/mm2, 10% FBS) at 
24 hours (A) and 120 hours (B) without media change, and coculture conditions (4.1x104 
cells/mm2, 2% FBS) 107 hours without media change (C). Image data show less than 1% of cells 
uptake trypan blue in coculture conditions, 10X. 
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Figure 29. Matrigel Increases 3-Dimensional Overlap of Myotubes. Comparison of myotubes 
grown on Matrigel-coated cover glass (A) and untreated cover glass (B) for 96 hours post-strain. 
Both resulted in relatively equal differentiation, however the 3-dimensionality of the Matrigel 
increased myotubes stacking on top of each other and confounded contraction data. 
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Figure 30. Calcium Dependent Adhesion Molecules Decrease Maximal Shortening. A. 
Fractional shortening of myotubes in response to ACh [1-11-1-3M] and KCl [1-2M] normalized to a 
percentage of their original resting area. PBS-only was given sham treatment. B. Dose response 
curves of myotubes as a % max contraction induced by 10mM KCl. C. Corresponding table of 
values for in vitro myotube contraction; N=3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment Maximum Shortening [ACh] ED50 Log 
[ACh] 
Slope 
Coefficient 
R2 
0 mM Ca2+ 68.7 ± 3.8%γ -7.45 ± 1.10 -0.206 ± 0.1 0.94 
1.8 mM Ca2+ 78.5 ± 4.3% -7.42 ± 0.48 -0.443 ± 0.3 0.95 
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Figure 31. ABGT Blockade of NAChRs. C. We were able to completely block myotube AChRs 
with 5µg/ml αBGT. We therefore incubated myotubes in 5µg/ml αBGT and attempted to contract 
them using ACh. D.  No cytotoxic effects were observed at any dosage of αBGT after 1 hour. 
These data will be discussed, but not shown, in the manuscript. 
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Size (µm2) Population Top LogEC50 EC50 Hill slope 
>10000 11 92.2±3.5 -8.60±0.17 2.51nM 0.51±0.09 
10000 - 7500 12 93.7±3.2 -8.77±0.17 1.70nM 0.70±0.12 
7500 - 5000 28 92.1±1.8 -9.16±0.09 692pM 0.85±0.36 
5000 - 2500 51 82.3±2.3 -8.10 ± NA 7.94nM 8.03±NA 
<2500 18 89.2±3.3 -8.27 ± NA 5.37nM 5.13±NA 
 
 
Figure 32. Effects of Cell Size on In Vitro Myotube Contraction. All myotubes used to 
calculate non-strain coculture results were divided into one of five size brackets and the EC50 and 
Hill slope. While no changes in contractile sensitivity could be measured, the hill slope shows a 
clear trend in which an all or nothing contraction occurs for smaller myotubes. 
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Figure 33. Agrin Treatment Does Not Affect NAChR Expression. Myotubes differentiated in 
horse serum and treated with agrin and untreated myotubes were assessed for AChR expression 
by Western blot, N=4.  
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Figure 34. Reorganization Ratio of NAChR Clusters. Ratio is defined as the percentage of 
macroclusters to all αBGT-stained regions on the myotubes; macroclusters and microclusters. 
The double line separates agrin experiments from coculture experiments. The average from all 
imaging data were statistically compared by ANOVA with posthoc Tukey to calculate significance 
among groups; δ>- agrin, τ> CSDS, λ> CSDS+ALDS, N=11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment Reorganization ratio 
+ Agrin 18.0 ± 2.7%δ 
- Agrin 4.0 ±  2.3% 
Uniculture 5.9 ±  1.7% 
Non-strain 9.7 ±  1.3% 
ALDS 15.8 ± 1.1%*,Τ,λ 
CSDS 7.0 ±  1.4% 
CSDS+ALDS 5.9 ±  1.3% 
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Figure 35. Fibroblasts Enhance Human Myoblasts Differentiation. Hematoxylin and eosin-
stained image of HSMM differentiated in coculture at 120 hours (A).  Myotubes were identified as 
≥3 nuclei. Graph confirms that fibroblasts and strain upregulate human skeletal muscle myoblasts 
(HSMM) differentiation; *>uniculture, N=5. 
 
